setgskqijmsmsagcnqmiqopodamagojeumuapamm length 6 144634 page 144634 <!DOCTYPE html><html lang="en" dir="ltr"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/><link rel="icon" href="https://cdn.theatlantic.com/_next/static/images/favicon-3888b0e329526a975703e3059a02b92d.ico"/><link rel="apple-touch-icon" href="https://cdn.theatlantic.com/_next/static/images/apple-touch-icon-default-b504d70343a9438df64c32ce339c7ebc.png"/><link rel="apple-touch-icon" sizes="76x76" href="https://cdn.theatlantic.com/_next/static/images/apple-touch-icon-76x76-d5accc11b8265af76495fbfa9d38dd3b.png"/><link rel="apple-touch-icon" sizes="120x120" href="https://cdn.theatlantic.com/_next/static/images/apple-touch-icon-120x120-419ba228184c040a691628d3dd82c206.png"/><link rel="apple-touch-icon" sizes="152x152" href="https://cdn.theatlantic.com/_next/static/images/apple-touch-icon-152x152-aafde20dd981a38fcd549b29b2b3b785.png"/><meta name="application-name" content="theatlantic"/><meta name="msapplication-TileColor" content="#FFFFFF"/><meta name="msapplication-TileImage" content="https://cdn.theatlantic.com/_next/static/images/apple-touch-icon-default-b504d70343a9438df64c32ce339c7ebc.png"/><meta property="og:site_name" content="The Atlantic"/><meta property="og:locale" content="en_US"/><meta property="fb:admins" content="577048155,17301937"/><meta property="fb:app_id" content="100770816677686"/><meta property="fb:pages" content="29259828486,1468531833474495,1061579677251147,457711054591520,370457103090695,1631141167169115,148681772342453,1510507419185410,128344747344340,128377530562508,236061986423933"/><meta name="p:domain_verify" content="68e1a0361a557708fefc992f3309ed70"/><meta name="twitter:site" content="@theatlantic"/><meta name="twitter:domain" content="theatlantic.com"/><script type="application/ld+json">{"@context":"https://schema.org","@type":"WebSite","name":"The Atlantic","url":"https://www.theatlantic.com","inLanguage":"en-US","issn":"1072-7825","potentialAction":{"@type":"SearchAction","target":"https://www.theatlantic.com/search/?q={q}","query-input":"required name=q"}}</script><script type="application/ld+json">{"@context":"https://schema.org","@type":"Organization","@id":"https://www.theatlantic.com/#publisher","name":"The Atlantic","url":"https://www.theatlantic.com","logo":{"@type":"ImageObject","width":{"@type":"QuantitativeValue","unitCode":"E37","value":224},"height":{"@type":"QuantitativeValue","unitCode":"E37","value":224},"url":"https://cdn.theatlantic.com/assets/media/files/atlantic-logo--224x224.png"},"sameAs":["https://www.facebook.com/TheAtlantic","https://twitter.com/theatlantic"]}</script><style id="_vis_opt_path_hide">#paywall,#nonMeteredNudge,#gate {opacity:0;}</style><title>A COVID-19 Vaccine Reality Check - The Atlantic</title><meta name="description" content="So much hope is riding on a breakthrough, but a vaccine is only the beginning of the end."/><meta property="krux:title" content="A COVID-19 Vaccine Reality Check - The Atlantic"/><meta property="krux:description" content="So much hope is riding on a breakthrough, but a vaccine is only the beginning of the end."/><link rel="canonical" href="https://www.theatlantic.com/health/archive/2020/07/covid-19-vaccine-reality-check/614566/"/><link rel="image_src" href="https://cdn.theatlantic.com/thumbor/NW2cvzKrcby91SzmIiqES4YNWvM=/0x43:2000x1085/1200x625/media/img/mt/2020/07/vaccine/original.jpg"/><meta name="author" content="Sarah Zhang"/><link rel="ia:markup_url" href="https://www.theatlantic.com/facebook-instant/article/614566/"/><meta property="article:publisher" content="https://www.facebook.com/TheAtlantic/"/><meta property="article:opinion" content="false"/><meta property="article:content_tier" content="metered"/><meta property="article:tag" content="science"/><meta property="article:section" content="Health"/><meta property="article:published_time" content="2020-07-24T14:12:42Z"/><meta property="article:modified_time" content="2021-02-23T18:53:59Z"/><meta name="robots" content="index, follow, max-image-preview:large"/><meta property="og:title" content="A Vaccine Reality Check"/><meta property="og:description" content="So much hope is riding on a breakthrough, but a vaccine is only the beginning of the end."/><meta property="og:url" content="https://www.theatlantic.com/health/archive/2020/07/covid-19-vaccine-reality-check/614566/"/><meta property="og:type" content="article"/><meta property="og:image" content="https://cdn.theatlantic.com/thumbor/NW2cvzKrcby91SzmIiqES4YNWvM=/0x43:2000x1085/1200x625/media/img/mt/2020/07/vaccine/original.jpg"/><meta property="twitter:card" content="summary_large_image"/><meta name="FacebookShareMessage" content="Even on a sped-up timeline a vaccine is still months away. But once it arrives it&#x27;s unlikely to meet all the hopes we&#x27;ve placed in it, writes @sarahzhang:"/><meta name="TwitterShareMessage" content="Even on a sped-up timeline a vaccine is still months away. But once it arrives it&#x27;s unlikely to meet all the hopes we&#x27;ve placed in it, writes @sarahzhang:"/><link rel="alternate" type="application/rss+xml" title="The Atlantic" href="/feed/all/"/><link rel="alternate" type="application/rss+xml" title="Best of The Atlantic" href="/feed/best-of/"/><meta name="referrer" content="unsafe-url"/><meta name="apple-mobile-web-app-capable" content="yes"/><meta name="apple-mobile-web-status-bar-style" content="black"/><meta name="apple-mobile-web-app-title" content="The Atlantic"/><meta name="keywords" content="hypothetical vaccine, COVID-19 virus, COVID-19 vaccine, rosy projections of a vaccine, blow coverage of vaccine trials, much simpler task, H1N1, record time, vaccine optimism, director of the National Immunization Program, vaccine, given participant, director of the World Health Organization, initial results, local health departments, good news, immune system, FDA’s pandemic response, Trump administration’s Operation Warp Speed, American company, CDC buys, vaccine distribution efforts, director of the University of Maryland, willingness of people, Trump administration, candidate vaccines, human trials, long-term immune response, early success, Kelly Moore, careful planning, Disease Control, good reasons, Normal life, recent weeks, promise of a vaccine, herd immunity, high expectations, federal government, patchwork of state, next challenges, Emory University, real world, late June, COVID-19 vaccines, huge group, severe disease, given amount of eggs, older adults.Some of the leading COVID-19, Johns Hopkins University" itemID="#keywords"/><meta name="news_keywords" content="hypothetical vaccine, COVID-19 virus, COVID-19 vaccine, rosy projections of a vaccine, blow coverage of vaccine trials, much simpler task, H1N1, record time, vaccine optimism, director of the National Immunization Program, vaccine, given participant, director of the World Health Organization, initial results, local health departments, good news, immune system, FDA’s pandemic response, Trump administration’s Operation Warp Speed, American company, CDC buys, vaccine distribution efforts, director of the University of Maryland, willingness of people, Trump administration, candidate vaccines, human trials, long-term immune response, early success, Kelly Moore, careful planning, Disease Control, good reasons, Normal life, recent weeks, promise of a vaccine, herd immunity, high expectations, federal government, patchwork of state, next challenges, Emory University, real world, late June, COVID-19 vaccines, huge group, severe disease, given amount of eggs, older adults.Some of the leading COVID-19, Johns Hopkins University"/><meta name="sailthru.title" content="A Vaccine Reality Check"/><meta name="sailthru.tags" content="health,science,coronavirus-covid-19,corrections,author-sarah-zhang"/><meta name="sailthru.date" content="2020-07-24T14:12:42Z"/><link rel="preload" as="font" type="font/woff2" href="https://www.theatlantic.com/packages/fonts/garamond/AGaramondPro-Regular.woff2" crossorigin=""/><link rel="preload" as="font" type="font/woff2" href="https://www.theatlantic.com/packages/fonts/graphik/Graphik-Regular-Web.woff2" crossorigin=""/><link rel="preload" as="font" type="font/woff2" href="https://www.theatlantic.com/packages/fonts/graphik/Graphik-Semibold-Web.woff2" crossorigin=""/><link rel="preload" as="font" type="font/woff2" href="https://www.theatlantic.com/packages/fonts/logic/LogicMonospace-Medium.woff2" crossorigin=""/><link rel="preload" as="font" type="font/woff2" href="https://www.theatlantic.com/packages/fonts/logic/LogicMonospace-Regular.woff2" crossorigin=""/><script type="application/ld+json">{"@context":"https://schema.org","@type":"NewsArticle","headline":"A COVID-19 Vaccine Reality Check","alternativeHeadline":"A Vaccine Reality Check","description":"So much hope is riding on a breakthrough, but a vaccine is only the beginning of the end.","url":"https://www.theatlantic.com/health/archive/2020/07/covid-19-vaccine-reality-check/614566/","datePublished":"2020-07-24T14:12:42Z","dateModified":"2021-02-23T18:53:59Z","isAccessibleForFree":false,"hasPart":{"@type":"WebPageElement","isAccessibleForFree":false,"cssSelector":".article-content-body"},"publisher":{"@id":"https://www.theatlantic.com/#publisher"},"mainEntityOfPage":{"@type":"WebPage","@id":"https://www.theatlantic.com/health/archive/2020/07/covid-19-vaccine-reality-check/614566/"},"image":[{"@type":"ImageObject","width":{"@type":"QuantitativeValue","unitCode":"E37","value":720},"height":{"@type":"QuantitativeValue","unitCode":"E37","value":405},"url":"https://cdn.theatlantic.com/thumbor/ZcTdBc0e0-M1_DLPH-aapb21b88=/0x0:2000x1125/720x405/media/img/mt/2020/07/vaccine/original.jpg"},{"@type":"ImageObject","width":{"@type":"QuantitativeValue","unitCode":"E37","value":1080},"height":{"@type":"QuantitativeValue","unitCode":"E37","value":1080},"url":"https://cdn.theatlantic.com/thumbor/tCfwm2aoxKmojZQFFZwA3bFplTY=/288x0:1488x1200/1080x1080/media/img/mt/2020/07/vaccine/original.jpg"},{"@type":"ImageObject","width":{"@type":"QuantitativeValue","unitCode":"E37","value":1200},"height":{"@type":"QuantitativeValue","unitCode":"E37","value":900},"url":"https://cdn.theatlantic.com/thumbor/bIBd-MKkwS4qolxCoiMqpuyw3-E=/201x0:1801x1200/1200x900/media/img/mt/2020/07/vaccine/original.jpg"},{"@type":"ImageObject","width":{"@type":"QuantitativeValue","unitCode":"E37","value":1600},"height":{"@type":"QuantitativeValue","unitCode":"E37","value":900},"url":"https://cdn.theatlantic.com/thumbor/t17vZplO_1uKBgUzhDtfOsRH6x0=/0x0:2000x1125/1600x900/media/img/mt/2020/07/vaccine/original.jpg"},{"@type":"ImageObject","width":{"@type":"QuantitativeValue","unitCode":"E37","value":960},"height":{"@type":"QuantitativeValue","unitCode":"E37","value":540},"url":"https://cdn.theatlantic.com/thumbor/qK60q2VIyUzp6LkmcZ4UQd-UFLA=/0x0:2000x1125/960x540/media/img/mt/2020/07/vaccine/original.jpg"},{"@type":"ImageObject","width":{"@type":"QuantitativeValue","unitCode":"E37","value":540},"height":{"@type":"QuantitativeValue","unitCode":"E37","value":540},"url":"https://cdn.theatlantic.com/thumbor/m4MP7qujn6bnjuE9ZcCH_fgHXus=/288x0:1488x1200/540x540/media/img/mt/2020/07/vaccine/original.jpg"}],"author":[{"@type":"Person","name":"Sarah Zhang","sameAs":"https://www.theatlantic.com/author/sarah-zhang/"}],"articleSection":"Health"}</script><link rel="preload" as="image" href="https://cdn.theatlantic.com/thumbor/qK60q2VIyUzp6LkmcZ4UQd-UFLA=/0x0:2000x1125/960x540/media/img/mt/2020/07/vaccine/original.jpg" imageSrcSet="https://cdn.theatlantic.com/thumbor/cKLkauea62Nlf75LVVYCK4H9r5s=/0x0:2000x1125/750x422/media/img/mt/2020/07/vaccine/original.jpg 750w, https://cdn.theatlantic.com/thumbor/c4qgE2R4322aq0_K0NTdKQSrHLk=/0x0:2000x1125/828x466/media/img/mt/2020/07/vaccine/original.jpg 828w, https://cdn.theatlantic.com/thumbor/qK60q2VIyUzp6LkmcZ4UQd-UFLA=/0x0:2000x1125/960x540/media/img/mt/2020/07/vaccine/original.jpg 960w, https://cdn.theatlantic.com/thumbor/UdTFdSQJm09i7wMw092LNkJ7bfQ=/0x0:2000x1125/976x549/media/img/mt/2020/07/vaccine/original.jpg 976w, https://cdn.theatlantic.com/thumbor/u7u8OF_Iu9rFRkYl02ps9CxArhs=/0x0:2000x1125/1952x1098/media/img/mt/2020/07/vaccine/original.jpg 1952w" imageSizes="(min-width: 976px) 976px, 100vw"/><meta name="next-head-count" content="63"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/css/bbbe8b88f7ceae18.css" as="style"/><link rel="stylesheet" href="https://cdn.theatlantic.com/_next/static/css/bbbe8b88f7ceae18.css" data-n-g=""/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/css/71271caf73c03f03.css" as="style"/><link rel="stylesheet" href="https://cdn.theatlantic.com/_next/static/css/71271caf73c03f03.css" data-n-p=""/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/css/262bf55861dba4be.css" as="style"/><link rel="stylesheet" href="https://cdn.theatlantic.com/_next/static/css/262bf55861dba4be.css" data-n-p=""/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/css/6952c11007332d68.css" as="style"/><link rel="stylesheet" href="https://cdn.theatlantic.com/_next/static/css/6952c11007332d68.css" data-n-p=""/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/css/aa73585f9549bd63.css" as="style"/><link rel="stylesheet" href="https://cdn.theatlantic.com/_next/static/css/aa73585f9549bd63.css" data-n-p=""/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/css/fab00e38ce592186.css" as="style"/><link rel="stylesheet" href="https://cdn.theatlantic.com/_next/static/css/fab00e38ce592186.css"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/css/41e276093706f93d.css" as="style"/><link rel="stylesheet" href="https://cdn.theatlantic.com/_next/static/css/41e276093706f93d.css"/><noscript data-n-css=""></noscript><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/6449.a042cba4e409376f.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/2839.8701ee48b3142129.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/webpack-8be99a45ef49291a.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/framework-2114f3935436c3d0.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/main-61b21f44401e8a5c.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/pages/_app-334f9b7f2dda768e.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/6729-85e40cec85603df8.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/5303-aa03f19b365778fd.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/2746-f19d6369806ca564.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/1902-6d7b58897f1bfa3b.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/2739-516bd5912f0bb1d8.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/3634-78db02a401df82c2.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/8879-1834efe4206c6b1c.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/4634-74c19fdccf77b65c.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/6759-404ffcc76f0619cc.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/7218-70290618c2e802bb.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/7455-e721c97706669282.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/7124-4bf2b2d7b62898f6.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/4603-1caa64ad3f882c0c.js" as="script"/><link rel="preload" href="https://cdn.theatlantic.com/_next/static/chunks/pages/%5Bchannel%5D/archive/%5Byear%5D/%5Bmonth%5D/%5Bslug%5D/%5Bid%5D-1989daf459a7e5aa.js" as="script"/></head><body><div id="__next"><div data-category="story page" data-event-surface="article"><div></div><nav class="Nav_root__HcZek" aria-labelledby="site-navigation" data-category="Site Nav" data-event-module="site nav" id="main-navigation"><div class="Nav_mainNav__iPsWc"><a href="#main-content" class="Nav_skipLink__P4Y5R">Skip to content</a><h2 id="site-navigation" class="Nav_visuallyHide__Lzzui">Site Navigation</h2><div class="Nav_flexContainer__9iJ4H"><ul class="Nav_leftContainer__Xs54R"><li class="Nav_navListItem__l2afO Nav_visuallyHideOnMobile__N9bs2"><a href="/" class="Nav_navLink__34Bol"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 87.83 134" class="Nav_bigA__c1aIb"><title>The Atlantic</title><path d="M24.48 95.13c-.56 0-.74-.37-.74-.93l13.08-55.88c.19-.94.93-.94 1.12 0L50.09 94.2c0 .56-.19.93-.75.93zM48.22.19a22.54 22.54 0 01-7.66 5.05c-.75.19-.94.37-1.13 1.12l-26.72 112.5c-2 9-4.67 10.66-11.77 11.22a.88.88 0 00-.94.93v2.06a.88.88 0 00.92.93h25.6a.88.88 0 00.93-.93V131a.88.88 0 00-.93-.93c-9.53 0-10.47-2.81-8.6-10.66l4.49-19.25a1.18 1.18 0 011.12-.93h26.74a1.19 1.19 0 011.13.93l5 23.18c1.12 5-.75 6.17-7.1 6.73a.88.88 0 00-.93.93v2.06a.88.88 0 00.93.93h37.62a.88.88 0 00.94-.93V131a.88.88 0 00-.94-.93c-5.79-.56-8.22-1.5-9.34-6.73L49.34.57c-.19-.56-.75-.75-1.12-.38"></path></svg></a></li><li class="Nav_navListItem__l2afO Nav_hamburgerLi__gP6Dn"><button class="NavHamburgerButton_root__OgJkB" aria-expanded="false" aria-controls="expanded-nav" aria-label="Open Main Menu" data-action="Open Menu"><div class="NavHamburgerButton_burger__jIWmI"><div class="NavHamburgerButton_box__J5rDn"><div class="NavHamburgerButton_inner__dKlIy"></div></div></div></button><div class="Nav_expandedNav__o5Zj_"><div hidden="" class="ExpandedNav_root__r3hKE" id="expanded-nav"><div class="ExpandedNav_mobileHeader__QEenD" data-event-element="mobile links"><button class="ExpandedNav_searchButton__85mWm" aria-label="Search The Atlantic" data-action="open search"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 16 16" class="ExpandedNav_searchIcon__2EngD"><path d="M15.85 15.15l-5.27-5.28a6 6 0 10-.71.71l5.28 5.27a.48.48 0 00.7 0 .48.48 0 000-.7zM1 6a5 5 0 115 5 5 5 0 01-5-5z"></path></svg></button><div><a class="ExpandedNav_mostPopular__EbSyn" href="/most-popular/" data-action="expanded">Popular</a><a class="ExpandedNav_latest__zSrBe" href="/latest/" data-action="expanded">Latest</a><a class="ExpandedNav_newsletters__W83ni" href="/newsletters/" data-action="expanded">Newsletters</a></div></div><div class="ExpandedNav_container__sDhOz"><div class="ExpandedNav_sections__oGeXo" data-event-element="sections"><h2 class="ExpandedNav_title__C8QcN ExpandedNav_sectionTitle___xWBI">Sections</h2><ul class="ExpandedNav_sectionUl__mLUY1"><li class="ExpandedNav_sectionLi__tZz7K"><a href="/politics/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Politics</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/ideas/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Ideas</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="https://www.theatlantic.com/category/fiction/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Fiction</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/technology/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Technology</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/science/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Science</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="https://www.theatlantic.com/photo/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Photo</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/business/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Business</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/culture/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Culture</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/projects/planet/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Planet</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/international/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Global</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/books/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Books</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/audio/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Audio</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/health/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Health</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/education/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Education</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/projects/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Projects</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="https://www.theatlantic.com/category/features/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Features</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/family/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Family</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/events/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Events</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="https://www.theatlantic.com/category/washington-week-atlantic/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Washington Week</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="https://www.theatlantic.com/progress/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Progress</a></li><li class="ExpandedNav_sectionLi__tZz7K"><a href="/newsletters/" data-action="expanded" class="ExpandedNav_sectionLink__3iXo9">Newsletters</a></li></ul></div><div class="ExpandedNav_moreLinks__G4VPb" data-event-element="more links"><ul class="ExpandedNav_moreLinksList__u0bVY"><li class="ExpandedNav_moreLinksListItem__UrTkv"><a href="/archive/" class="ExpandedNav_moreLinksItem__JhFzM" data-action="archive"><img alt="" loading="lazy" class="Image_root__XxsOp Image_lazy__hYWHV ExpandedNav_moreLinksImg__IY3fl" src="https://cdn.theatlantic.com/_next/static/images/nav-archive-promo-5541b02ae92f1a9276249e1c6c2534ee.png" width="80" height="80"/><span>Explore The Atlantic Archive</span></a></li><li class="ExpandedNav_moreLinksListItem__UrTkv"><a href="/free-daily-crossword-puzzle/" class="ExpandedNav_moreLinksItem__JhFzM" data-action="crossword"><svg width="80" height="80" viewBox="0 0 64 64" fill="none" xmlns="http://www.w3.org/2000/svg" class="ExpandedNav_moreLinksImg__IY3fl"><g clip-path="url(#crossword-promo_svg__clip0_1939_66324)"><path fill="#E7131A" d="M0 0h64v64H0z"></path><path d="M37.988 26.531H26.516v11.474h11.472V26.53zM37.988 38.805H26.516V50.28h11.472V38.805zM25.715 26.531H14.243v11.474h11.472V26.53zM50.26 26.531H38.789v11.474h11.473V26.53zM36.469 16.842c.096.183.156.39.156.612a1.326 1.326 0 11-1.326-1.327c.197 0 .384.047.552.124.167-.464.303-1.137.338-1.993h-5.287c-.039.968-.217 1.908-.527 2.584.096.183.156.39.156.612a1.326 1.326 0 11-1.327-1.327c.198 0 .384.047.552.124.167-.464.303-1.137.339-1.993h-3.58v11.474h11.472V14.258h-.992c-.038.968-.216 1.908-.526 2.584z" fill="#fff"></path><path d="M47.487 17.853a.4.4 0 010-.8c.135 0 .36-.27.552-.803a1.313 1.313 0 00-.552-.124 1.326 1.326 0 101.326 1.327c0-.222-.06-.428-.156-.612-.282.615-.674 1.012-1.17 1.012zM41.393 17.853a.4.4 0 010-.8c.135 0 .36-.27.552-.803a1.313 1.313 0 00-.552-.124 1.326 1.326 0 101.326 1.327c0-.222-.06-.428-.156-.612-.282.615-.673 1.012-1.17 1.012zM35.298 17.853a.4.4 0 010-.8c.135 0 .36-.27.552-.803a1.313 1.313 0 00-.552-.124 1.326 1.326 0 101.326 1.327c0-.222-.06-.428-.156-.612-.282.615-.673 1.012-1.17 1.012zM29.204 17.853a.4.4 0 010-.8c.136 0 .36-.27.552-.803a1.313 1.313 0 00-.552-.124 1.326 1.326 0 101.327 1.327c0-.222-.06-.428-.156-.612-.282.615-.673 1.012-1.17 1.012zM23.11 17.853a.4.4 0 010-.8c.135 0 .36-.27.552-.803a1.313 1.313 0 00-.552-.124 1.326 1.326 0 101.326 1.327c0-.222-.06-.428-.156-.612-.282.615-.673 1.012-1.17 1.012zM17.016 17.853a.4.4 0 010-.8c.135 0 .36-.27.552-.803a1.313 1.313 0 00-.552-.124 1.326 1.326 0 101.326 1.327c0-.222-.06-.428-.156-.612-.282.615-.672 1.012-1.17 1.012z" fill="#E7131A"></path><path d="M50.66 13.458h-1.476c-.072-1.85-.652-3.605-1.698-3.605-1.045 0-1.624 1.753-1.697 3.605h-2.7c-.071-1.85-.651-3.605-1.698-3.605-1.045 0-1.624 1.753-1.697 3.605h-2.7c-.072-1.85-.652-3.605-1.698-3.605-1.045 0-1.624 1.753-1.697 3.605H30.9c-.072-1.85-.652-3.605-1.698-3.605-1.045 0-1.624 1.753-1.697 3.605h-2.697c-.072-1.85-.652-3.605-1.698-3.605-1.045 0-1.624 1.753-1.697 3.605h-2.7c-.071-1.85-.651-3.605-1.698-3.605-1.045 0-1.624 1.753-1.697 3.605h-1.476a.4.4 0 00-.4.4V50.68c0 .22.18.4.4.4H50.66a.4.4 0 00.4-.4V13.858c0-.221-.178-.4-.4-.4zm-20.565.8c-.035.855-.171 1.528-.338 1.992-.192.532-.417.803-.552.803a.4.4 0 000 .8c.497 0 .888-.398 1.17-1.012.31-.676.488-1.616.527-2.583h5.288c-.036.855-.172 1.528-.339 1.992-.192.532-.417.803-.552.803a.4.4 0 000 .8c.498 0 .888-.398 1.17-1.012.311-.676.489-1.616.528-2.583h.992V25.73H26.515V14.258h3.58zm20.166 23.747H38.788V26.53h11.473v11.474zM14.243 26.53h11.472v11.474H14.243V26.53zm34.57-9.078a1.326 1.326 0 11-1.327-1.327c.198 0 .384.047.552.124-.192.532-.416.803-.552.803a.4.4 0 000 .8c.498 0 .888-.398 1.17-1.012.097.184.157.39.157.612zm-7.42.4c.497 0 .888-.398 1.17-1.012.096.183.156.39.156.612a1.326 1.326 0 11-1.326-1.327c.197 0 .384.047.552.124-.192.532-.417.803-.552.803a.4.4 0 000 .8zm-3.405 20.152H26.515V26.53h11.473v11.474zM24.436 17.453a1.326 1.326 0 11-1.326-1.327c.197 0 .384.047.552.124-.192.532-.417.803-.552.803a.4.4 0 000 .8c.497 0 .888-.398 1.17-1.012.097.184.156.39.156.612zm-6.094 0a1.326 1.326 0 11-1.326-1.327c.198 0 .384.047.552.124-.192.532-.417.803-.552.803a.4.4 0 000 .8c.498 0 .888-.398 1.17-1.012.097.184.156.39.156.612zm8.173 21.352h11.473V50.28H26.515V38.805zm20.971-28.152c.253 0 .817.96.892 2.805h-1.782c.075-1.844.638-2.805.89-2.805zm-6.093 0c.253 0 .817.96.891 2.805h-1.782c.076-1.844.638-2.805.89-2.805zm-6.095 0c.253 0 .817.96.892 2.805h-1.782c.075-1.844.638-2.805.89-2.805zm-6.094 0c.253 0 .817.96.891 2.805h-1.781c.075-1.844.637-2.805.89-2.805zm-6.094 0c.252 0 .816.96.89 2.805h-1.78c.074-1.844.637-2.805.89-2.805zm-6.094 0c.253 0 .817.96.891 2.805h-1.781c.075-1.844.637-2.805.89-2.805z" fill="#000"></path></g><defs><clipPath id="crossword-promo_svg__clip0_1939_66324"><path fill="#fff" d="M0 0h64v64H0z"></path></clipPath></defs></svg><span>Play The Atlantic crossword</span></a></li><li class="ExpandedNav_moreLinksListItem__UrTkv"><a href="/audio/" class="ExpandedNav_moreLinksItem__JhFzM" data-action="audio"><svg width="80" height="80" viewBox="0 0 64 64" fill="none" xmlns="http://www.w3.org/2000/svg" class="ExpandedNav_moreLinksImg__IY3fl"><path fill="#FAF4EB" d="M0 0h63.998v64H0z"></path><path d="M25.267 31.27h-1.171v12.138h1.17a.392.392 0 00.393-.392V31.662a.392.392 0 00-.392-.393v.002zM38.34 31.662v11.354c0 .217.175.392.392.392h1.171V31.271h-1.17a.392.392 0 00-.393.392v-.002z" fill="#000"></path><path d="M44.605 33.479c.106-.69.163-1.398.163-2.12 0-7.343-5.718-13.296-12.77-13.296-7.05 0-12.768 5.953-12.768 13.296 0 .722.057 1.429.163 2.12l-1.413.58v6.56l2.033.834a3.194 3.194 0 001.586 1.65c.411.193.869.305 1.353.305h.34V31.271h-.34c-.174 0-.345.017-.511.044a3.14 3.14 0 00-1.236.48c-.005-.145-.011-.289-.011-.434 0-6.25 4.847-11.334 10.805-11.334 5.958 0 10.805 5.085 10.805 11.334 0 .145-.005.29-.01.433a3.163 3.163 0 00-1.748-.523h-.34v12.137h.34a3.197 3.197 0 002.939-1.953l2.033-.835v-6.56l-1.413-.58v-.001zM35.71 49.806a.498.498 0 100 .997.498.498 0 000-.997zM30.235 50.8a.498.498 0 100-.996.498.498 0 000 .997zM28.059 48.218a.498.498 0 100 .997.498.498 0 000-.997zM32.104 50.072a.498.498 0 100-.997.498.498 0 000 .997zM33.105 47.731a.498.498 0 100 .997.498.498 0 000-.997zM29.675 48.09a.498.498 0 10.996 0 .498.498 0 00-.996 0zM35.71 48.156a.498.498 0 10-.997 0 .498.498 0 00.997 0zM37.508 49.085a.498.498 0 100 .996.498.498 0 000-.996zM39 47.336a.498.498 0 100 .996.498.498 0 000-.996zM39.159 45.754a.498.498 0 100 .996.498.498 0 000-.996zM40.74 46.07a.498.498 0 100 .997.498.498 0 000-.997zM40.266 44.33a.498.498 0 100 .997.498.498 0 000-.997zM34.47 49.983a.498.498 0 10-.996 0 .498.498 0 00.997 0zM27.746 51.075a.498.498 0 100-.997.498.498 0 000 .997zM29.736 51.668a.498.498 0 100 .996.498.498 0 000-.996zM32.375 52.8a.498.498 0 100-.997.498.498 0 000 .997zM48.894 42.2a.498.498 0 100 .997.498.498 0 000-.997zM50.794 25.623a.497.497 0 10.7.082.497.497 0 00-.7-.082zM50.32 27.679a.497.497 0 10.7.082.497.497 0 00-.7-.082zM48.52 25.229a.497.497 0 10.78-.614.497.497 0 00-.78.614zM48.809 20.633a.498.498 0 10.616.781.498.498 0 00-.616-.781zM52.468 24.48a.497.497 0 10.78-.614.497.497 0 00-.78.615zM54.84 24.769a.498.498 0 10.617.781.498.498 0 00-.616-.781zM55.338 27.141a.497.497 0 10.782-.617.497.497 0 10-.782.617zM53.817 27.018a.497.497 0 10-.781.614.497.497 0 00.781-.614zM57.145 29.216a.498.498 0 10-.616-.781.498.498 0 00.616.781zM55.064 23.779a.498.498 0 10-.617-.782.498.498 0 00.617.782zM40.054 13.142a.498.498 0 10-.617-.781.498.498 0 00.617.781zM53.735 21.578a.498.498 0 10-.616-.78.498.498 0 00.616.78zM55.85 31.981a.497.497 0 10-.78.614.497.497 0 00.78-.614zM54.84 33.58a.498.498 0 10.617.781.498.498 0 00-.616-.78zM56.316 35.18a.497.497 0 10.617.784.497.497 0 00-.617-.783zM55.966 37.762a.498.498 0 10.616.781.498.498 0 00-.616-.781zM56.498 33.18a.498.498 0 10.617.781.498.498 0 00-.617-.781zM53.13 41.909a.498.498 0 10.617.78.498.498 0 00-.617-.78zM42.078 49.183a.498.498 0 10.617.781.498.498 0 00-.617-.781zM40.255 50.41a.498.498 0 10.616.782.498.498 0 00-.616-.782zM36.42 51.49a.498.498 0 10.618.782.498.498 0 00-.617-.782zM33.851 51.728a.498.498 0 10.617.78.498.498 0 00-.617-.78zM38.312 50.842a.498.498 0 10.616.781.498.498 0 00-.616-.78zM50.653 43.918a.498.498 0 10-.617-.78.498.498 0 00.617.78zM50.393 44.936a.498.498 0 10.616.782.498.498 0 00-.616-.782zM57.489 31.298a.497.497 0 10-.782.617.497.497 0 10.782-.617zM51.652 19.689a.497.497 0 10-.617-.784.497.497 0 00.617.784zM51.154 21.688a.498.498 0 10-.616-.782.498.498 0 00.616.782zM48.69 19.641a.497.497 0 10.781-.614.497.497 0 00-.781.614zM48.465 17.63a.498.498 0 10-.617-.782.498.498 0 00.617.781zM46.498 16.596a.5.5 0 00.554-.435.5.5 0 00-.99-.118.5.5 0 00.436.553zM46.244 18.243a.5.5 0 00.435.554.5.5 0 00.554-.436.5.5 0 00-.435-.553.5.5 0 00-.554.435zM45.325 15.307a.5.5 0 00.554-.435.5.5 0 00-.989-.118.5.5 0 00.435.553zM42.096 13.917a.5.5 0 00.554-.435.5.5 0 00-.435-.553.5.5 0 00-.554.434.5.5 0 00.435.554zM49.606 18.61a.5.5 0 00.554-.435.5.5 0 00-.989-.119.5.5 0 00.435.554zM45.478 17.63a.498.498 0 10-.616-.782.498.498 0 00.616.781zM43.392 17.311a.497.497 0 10-.782.617.497.497 0 10.782-.617zM54.34 36.596a.498.498 0 10.781-.618.498.498 0 00-.782.618zM53.384 36.69a.498.498 0 10-.617-.782.498.498 0 00.617.782zM51.95 37.01a.497.497 0 10-.7-.082c.172.217.483.253.7.083zM53.176 31.27a.498.498 0 10.616.782.498.498 0 00-.616-.781zM54.792 30.407a.498.498 0 10.616.782.498.498 0 00-.616-.782zM52.13 32.454a.498.498 0 10.617.781.498.498 0 00-.617-.781zM53.656 35.098a.498.498 0 10-.616-.781.498.498 0 00.616.781zM53.384 30.417a.498.498 0 10-.617-.782.498.498 0 00.617.782zM54.654 28.826a.498.498 0 10-.616-.782.498.498 0 00.616.782zM51.187 31.662a.497.497 0 10-.781.616.497.497 0 10.781-.616zM48.774 26.268a.497.497 0 10.7.082.497.497 0 00-.7-.082zM49.475 29.322a.498.498 0 10-.617-.781.498.498 0 00.617.781zM49.974 33.465a.498.498 0 10-.617-.782.498.498 0 00.617.782zM50.242 35.438a.498.498 0 10-.616-.78.498.498 0 00.616.78zM48.915 34.097a.497.497 0 10-.662.742.497.497 0 00.662-.742zM47.957 35.54a.497.497 0 10-.662.743.497.497 0 10.662-.743zM47.582 37.525a.497.497 0 10-.662.743.497.497 0 10.662-.743zM51.792 34.599a.498.498 0 10-.617-.782.498.498 0 00.617.782zM49.54 29.909a.498.498 0 10.617.781.498.498 0 00-.617-.781zM52.032 28.215a.498.498 0 10.617.78.498.498 0 00-.617-.78zM53.158 26.426a.497.497 0 10-.7-.082c.171.217.483.253.7.082zM48.578 32.179a.498.498 0 10-.617-.782.498.498 0 00.617.782zM50.89 30.403a.5.5 0 00.988.118.5.5 0 00-.989-.118zM46.624 25.265a.498.498 0 10.617.78.498.498 0 00-.617-.78z" fill="#000"></path><path d="M45.827 31.83a.497.497 0 10.7.082.497.497 0 00-.7-.083zM47.58 33.16a.497.497 0 10-.781.613.497.497 0 00.781-.614zM47.74 27.738a.498.498 0 10-.616-.782.498.498 0 00.616.782zM47.95 30.243a.5.5 0 00-.99-.119.5.5 0 00.99.119zM46.367 30.243a.5.5 0 00-.99-.119.5.5 0 00.99.119zM46.683 28.345a.5.5 0 00-.99-.119.5.5 0 00.99.119zM45.734 26.921a.5.5 0 00-.99-.118.5.5 0 00.99.118zM51.545 23.233a.497.497 0 10.781-.614.497.497 0 00-.781.614zM6.538 28.26a.499.499 0 10.51-.853.499.499 0 00-.51.852zM7.67 26.127a.499.499 0 10.51-.854.499.499 0 00-.51.854zM22.566 14.925a.499.499 0 10.51-.853.499.499 0 00-.51.853zM14.93 46.545a.499.499 0 10-.51.854.499.499 0 00.51-.854zM14.43 45.648a.499.499 0 10-.856-.512.499.499 0 00.856.512zM8.545 24.343a.499.499 0 10.51-.853.499.499 0 00-.51.853zM9.538 22.678a.5.5 0 10.51-.853.5.5 0 00-.51.853zM8.556 29.822a.499.499 0 10-.856-.512.499.499 0 00.856.512zM17.15 16.267a.498.498 0 10-.616-.781.498.498 0 00.616.781zM6.896 33.144a.498.498 0 10-.616-.782.498.498 0 00.616.782zM9.125 33.325a.498.498 0 10-.616-.781.498.498 0 00.616.781zM7.207 34.31a.498.498 0 10-.782.617.498.498 0 00.782-.618zM15.916 46.436a.498.498 0 100-.997.498.498 0 000 .997zM16.595 48.48a.498.498 0 100-.996.498.498 0 000 .997zM18.442 49.436a.498.498 0 100-.997.498.498 0 000 .997zM13.869 18.485a.498.498 0 100-.997.498.498 0 000 .997zM18.393 15.409a.498.498 0 100-.997.498.498 0 000 .997zM21.04 14.363a.497.497 0 10-.701-.704.497.497 0 00.702.704zM25.524 12.75a.497.497 0 10-.702-.704.497.497 0 00.702.704zM28.182 12.285a.497.497 0 10-.702-.704.497.497 0 00.702.704zM18.673 47.005a.498.498 0 10-.997 0 .498.498 0 00.997 0zM12.707 42.075a.498.498 0 10-.001.997.498.498 0 000-.997zM12.512 39.8a.498.498 0 10-.07-.993.498.498 0 00.07.994zM10.954 40.65a.498.498 0 100-.997.498.498 0 000 .997zM11.492 41.112a.498.498 0 100 .996.498.498 0 000-.996zM9.543 41.143a.498.498 0 100 .997.498.498 0 000-.997zM14.316 40.844a.498.498 0 10-.996 0 .498.498 0 00.996 0zM13.704 38.478a.498.498 0 100-.996.498.498 0 000 .996zM15.03 36.2a.498.498 0 10-.997 0 .498.498 0 00.997 0zM14.652 33.933a.498.498 0 100-.997.498.498 0 000 .997zM11.635 35.752a.498.498 0 100-.997.498.498 0 000 .997zM12.41 33.66a.498.498 0 100-.996.498.498 0 000 .997zM8.618 37.754a.498.498 0 10-.996 0 .498.498 0 00.996 0zM8.329 39.347a.498.498 0 100 .996.498.498 0 000-.996zM11.083 38.577a.498.498 0 10-.997 0 .498.498 0 00.997 0zM10.124 37.434a.498.498 0 100-.996.498.498 0 000 .996zM7.317 36.843a.498.498 0 100-.997.498.498 0 000 .997zM12.525 37.447a.497.497 0 10-.702-.704.497.497 0 00.702.704zM12.242 29.982a.498.498 0 100 .996.498.498 0 000-.996zM9.54 35.253a.498.498 0 10-.997 0 .498.498 0 00.997 0zM11.192 33.647a.498.498 0 10-.996 0 .498.498 0 00.996 0zM15.171 28.82a.498.498 0 100-.997.498.498 0 000 .996zM17.296 28.661a.498.498 0 100-.997.498.498 0 000 .997zM16.7 29.59a.498.498 0 10-.997 0 .498.498 0 00.996 0zM18.282 30.064a.498.498 0 10-.996 0 .498.498 0 00.996 0zM19.386 21.03a.498.498 0 100 .996.498.498 0 000-.996zM17.714 32.372a.498.498 0 100-.997.498.498 0 000 .997zM16.665 33.488a.498.498 0 100-.996.498.498 0 000 .996zM16.225 35.07a.498.498 0 100-.997.498.498 0 000 .997zM16.665 36.63a.498.498 0 100-.997.498.498 0 000 .996zM11.908 25.748a.498.498 0 100-.997.498.498 0 000 .997zM15.123 21.001a.498.498 0 100 .997.498.498 0 000-.997zM15.047 20.157a.498.498 0 100-.997.498.498 0 000 .997zM16.58 18.614a.498.498 0 100-.996.498.498 0 000 .997zM15.621 17.62a.498.498 0 10.001-.997.498.498 0 000 .997zM13.37 20.775a.498.498 0 100-.997.498.498 0 000 .997zM11.91 20.248a.498.498 0 10.001-.996.498.498 0 000 .996zM11.35 21.843a.498.498 0 100-.997.498.498 0 000 .997zM14.343 26.426a.498.498 0 100-.996.498.498 0 000 .996zM13.206 25.16a.498.498 0 100-.997.498.498 0 000 .996zM11.76 27.034a.498.498 0 10.997 0 .498.498 0 00-.996 0zM9.499 25.113a.498.498 0 10.997 0 .498.498 0 00-.997 0zM13.357 22.923a.498.498 0 10-.07-.994.498.498 0 00.07.994zM11.248 23.943a.498.498 0 100-.997.498.498 0 000 .997zM9.829 30.444a.498.498 0 100-.997.498.498 0 000 .997zM6.477 30.706a.498.498 0 100-.996.498.498 0 000 .996zM40.136 14a.5.5 0 10.857.513.5.5 0 00-.857-.512zM39.218 15.744a.499.499 0 10.51-.853.499.499 0 00-.51.853zM39.038 17.507a.499.499 0 10.51-.853.499.499 0 00-.51.853zM37.456 17.982a.499.499 0 10.51-.853.499.499 0 00-.51.853zM41.253 15.885a.499.499 0 10.51-.854.499.499 0 00-.51.854zM41.353 17.536a.499.499 0 10-.857-.512.499.499 0 00.857.512zM8.566 31.717a.498.498 0 100-.997.498.498 0 000 .997zM9.944 31.593a.498.498 0 10.997 0 .498.498 0 00-.997 0zM11.185 29.07a.498.498 0 10.996 0 .498.498 0 00-.996 0zM8.995 27.706a.498.498 0 100-.997.498.498 0 000 .997zM10.51 28.41a.498.498 0 100-.997.498.498 0 000 .997zM13.48 29.227a.498.498 0 10.001-.996.498.498 0 000 .996zM15.417 32.092a.498.498 0 100-.997.498.498 0 000 .997zM13.704 32.215a.498.498 0 100-.997.498.498 0 000 .997zM14.501 30.37a.498.498 0 100-.997.498.498 0 000 .996zM44.77 48.378a.498.498 0 00-.518.85.498.498 0 00.518-.85zM44.012 45.958a.499.499 0 00.517-.85.498.498 0 00-.517.85zM42.917 46.809a.498.498 0 10-.851-.517.498.498 0 00.851.517zM46.904 44.45a.498.498 0 10.516-.849.498.498 0 00-.517.85zM46.057 44.471a.498.498 0 10-.852-.516.498.498 0 00.852.516zM44.79 43.206a.498.498 0 10-.851-.517.498.498 0 00.851.517zM46.407 46.65a.498.498 0 10-.852-.516.498.498 0 00.852.517zM44.657 47.563a.498.498 0 10-.852-.516.498.498 0 00.852.516zM46.963 47.375a.498.498 0 00-.517.85.498.498 0 00.517-.85zM39.595 48.876a.498.498 0 00-.518.85.498.498 0 00.518-.85zM41.32 47.967a.498.498 0 00-.517.849.498.498 0 00.517-.85zM36.547 47.83a.498.498 0 10.851.517.498.498 0 00-.851-.516zM33.264 45.833a.498.498 0 100 .997.498.498 0 000-.997zM35.394 45.468a.498.498 0 10-.997 0 .498.498 0 00.997 0zM36.23 46.249a.498.498 0 10.852.517.498.498 0 00-.852-.517zM37.813 44.351a.498.498 0 10.852.517.498.498 0 00-.852-.517zM47.713 45.044a.498.498 0 00-.517.85.498.498 0 00.517-.85zM49.34 44.473a.499.499 0 00-.518.85.498.498 0 00.518-.85zM48.94 46.502a.498.498 0 10-.516.849.498.498 0 00.516-.849zM50.182 41.493a.498.498 0 10.347.933.498.498 0 00-.347-.933zM49.576 40.558a.498.498 0 10-.934.348.498.498 0 00.934-.348zM46.79 42.667a.498.498 0 10-.346-.933.498.498 0 00.347.933zM47.899 39.962a.498.498 0 10-.933.348.498.498 0 00.933-.348zM51.826 41.47a.497.497 0 10-.346-.932.497.497 0 00.346.933zM49.417 38.224a.498.498 0 10-.933.347.498.498 0 00.933-.347zM50.899 38.714a.498.498 0 10-.933.348.498.498 0 00.933-.348zM49.917 36.489a.498.498 0 10-.934.348.498.498 0 00.934-.348zM51.808 37.923a.498.498 0 10.347.933.498.498 0 00-.347-.933zM25.17 15.247a.498.498 0 100-.996.498.498 0 000 .996zM25.17 16.549a.498.498 0 10.998 0 .498.498 0 00-.997 0zM41.896 19.856a.498.498 0 10-.996 0 .498.498 0 00.996 0zM43.262 18.78a.498.498 0 100 .996.498.498 0 000-.997zM52.1 43.393a.498.498 0 10-.414.906.498.498 0 00.414-.906zM54.618 40.212a.496.496 0 00-.494.501.496.496 0 00.502.494.496.496 0 00.494-.502.496.496 0 00-.502-.493zM54.758 37.561a.496.496 0 00-.493.501.496.496 0 00.501.494.496.496 0 00.494-.502.496.496 0 00-.502-.493zM53.63 39.454a.496.496 0 00-.502-.493.497.497 0 10.502.494zM15.092 23.477a.498.498 0 10.347.932.498.498 0 00-.347-.932zM16.58 20.122a.498.498 0 10.996 0 .498.498 0 00-.997 0zM15.584 26.195a.498.498 0 10.997 0 .498.498 0 00-.997 0zM18.37 27.473a.498.498 0 100-.996.498.498 0 000 .996zM17.454 22.898a.498.498 0 100 .996.498.498 0 000-.996zM17.454 24.796a.498.498 0 100 .996.498.498 0 000-.996zM19.924 19.307a.498.498 0 100 .997.498.498 0 000-.997zM18.988 23.441a.498.498 0 10-.07-.994.498.498 0 00.07.994zM16.878 21.428a.498.498 0 100 .997.498.498 0 000-.997zM30.591 13.057a.497.497 0 10.346.932.497.497 0 00-.346-.932zM30.323 15.714a.498.498 0 10-.346-.933.498.498 0 00.346.933zM32.607 12.294a.498.498 0 100-.996.498.498 0 000 .996zM27.075 16.225a.498.498 0 10.933-.348.498.498 0 00-.933.348zM32.284 16.261a.498.498 0 10-.347-.933.498.498 0 00.347.933zM36.416 13.586a.499.499 0 10-.71-.699.499.499 0 00.71.7zM37.33 12.522a.499.499 0 10-.712-.7.499.499 0 00.712.7zM35.19 12.328a.499.499 0 10-.71-.7.499.499 0 00.71.7zM35.425 16.1a.499.499 0 10.697-.709.499.499 0 00-.697.709zM37.708 15.619a.499.499 0 10-.712-.7.499.499 0 00.712.7zM37.516 14.336a.499.499 0 10.697-.708.499.499 0 00-.697.708zM32.283 13.41a.499.499 0 10.711.7.499.499 0 00-.711-.7zM43.28 15.606a.499.499 0 10.71.7.499.499 0 00-.71-.7zM43.688 14.83a.499.499 0 10-.711-.7.499.499 0 00.71.7zM34.645 14.847a.499.499 0 10-.711-.699.499.499 0 00.711.7zM22.876 13.54a.499.499 0 10.51-.854.499.499 0 00-.51.855zM26.427 13.996a.499.499 0 10.51-.853.499.499 0 00-.51.853zM28.11 13.745a.499.499 0 10.857.511.499.499 0 00-.856-.511zM30.125 12.127a.499.499 0 10.51-.853.499.499 0 00-.51.853zM19.727 46.404a.498.498 0 10.139-.688.497.497 0 00-.14.69v-.002zM21.264 16.28a.498.498 0 10.584-.807.498.498 0 00-.584.807zM23.283 17.712a.497.497 0 10-.806-.584.497.497 0 00.806.584zM21.883 20.704a.497.497 0 10-.806-.584.497.497 0 00.806.584zM22.367 18.346a.498.498 0 10-.584.806.498.498 0 00.584-.806zM23.632 19.295a.498.498 0 10-.583.806.498.498 0 00.583-.806zM21.258 21.825a.498.498 0 10-.583.807.498.498 0 00.583-.807zM19.194 44.97a.498.498 0 10-.984-.156.498.498 0 00.984.155zM17.093 44.084a.498.498 0 10-.156.983.498.498 0 00.156-.983zM18.877 43.184a.498.498 0 10.156-.983.498.498 0 00-.156.983zM19.72 47.355a.498.498 0 10-.156.983.498.498 0 00.156-.983zM13.898 44.147a.498.498 0 10.156-.983.498.498 0 00-.156.983zM11.166 43.092a.498.498 0 10-.156.983.498.498 0 00.156-.983zM12.732 44.693a.497.497 0 10-.643.758.497.497 0 00.643-.758zM25.903 49.082a.498.498 0 10-.156.983.498.498 0 00.156-.983zM25.294 48.085a.497.497 0 10.983.156.497.497 0 00-.983-.156zM24.187 46.662a.498.498 0 10.983.155.498.498 0 00-.983-.155zM25.294 45.397a.498.498 0 10.983.155.498.498 0 00-.983-.155zM26.56 43.657a.498.498 0 10.983.155.498.498 0 00-.983-.155zM26.718 47.136a.498.498 0 10.983.156.498.498 0 00-.983-.156zM27.826 45.397a.498.498 0 10.983.155.498.498 0 00-.983-.155zM29.567 46.187a.497.497 0 10.982.156.497.497 0 00-.982-.156zM31.308 45.238a.498.498 0 10.983.156.498.498 0 00-.983-.156zM31.308 47.294a.498.498 0 10.983.156.498.498 0 00-.983-.156zM26.826 51.355a.498.498 0 10-.156.983.498.498 0 00.156-.983zM30.548 44.587a.498.498 0 10-.997 0 .498.498 0 00.997 0zM29.282 42.847a.498.498 0 10-.996 0 .498.498 0 00.996 0zM29.575 38.505a.498.498 0 100-.996.498.498 0 000 .996zM31.662 35.834a.498.498 0 10-.997 0 .498.498 0 00.997 0zM30.306 40.375a.498.498 0 100-.997.498.498 0 000 .997zM32.148 40.878a.498.498 0 10-.996 0 .498.498 0 00.996 0zM31.79 37.449a.498.498 0 100 .996.498.498 0 000-.996zM31.722 43.48a.498.498 0 100-.997.498.498 0 000 .997zM30.529 42.559a.498.498 0 100-.996.498.498 0 000 .996zM29.302 36.017a.498.498 0 100-.996.498.498 0 000 .996zM28.369 37.669a.498.498 0 10-.997 0 .498.498 0 00.997 0zM28.526 40.805a.498.498 0 100-.997.498.498 0 000 .997zM26.943 39.856a.498.498 0 100-.997.498.498 0 000 .997zM27.832 41.465a.497.497 0 10-.782.616.497.497 0 10.782-.617zM34.047 41.036a.498.498 0 10-.997 0 .498.498 0 00.997 0zM34.413 43.321a.498.498 0 100-.996.498.498 0 000 .996zM33.305 44.903a.498.498 0 100-.997.498.498 0 000 .997zM36.224 34.494a.498.498 0 10-.156.983.498.498 0 00.156-.983zM32.743 34.494a.498.498 0 10-.156.983.498.498 0 00.156-.983zM34.484 35.601a.498.498 0 10-.156.984.498.498 0 00.156-.984zM33.692 37.341a.498.498 0 10-.156.984.498.498 0 00.156-.984zM34.642 39.081a.498.498 0 10-.156.983.498.498 0 00.156-.983zM32.585 39.081a.498.498 0 10-.156.983.498.498 0 00.156-.983zM27.256 36.342a.498.498 0 10-.983-.156.498.498 0 00.983.156zM27.732 34.76a.498.498 0 10-.983-.156.498.498 0 00.983.156zM24.091 50.586a.497.497 0 10.2.974.497.497 0 00-.2-.974zM18.644 19.065a.498.498 0 100-.996.498.498 0 000 .996zM20.551 18.461a.498.498 0 100-.996.498.498 0 000 .996zM23.87 48.901a.498.498 0 10-.993.073.498.498 0 00.993-.073zM22.269 50.1a.498.498 0 10.072.994.498.498 0 00-.072-.994zM20.79 49.487a.498.498 0 10.072.993.498.498 0 00-.072-.993zM22.41 47.385a.498.498 0 10.994-.073.498.498 0 00-.993.073zM21.18 47.61a.498.498 0 10.072.994.498.498 0 00-.072-.993zM18.676 16.562a.498.498 0 10.934-.348.498.498 0 00-.934.348zM14.854 39.586a.498.498 0 100-.997.498.498 0 000 .997zM15.8 43.505a.498.498 0 10-.072-.993.498.498 0 00.072.993zM17.084 40.175a.498.498 0 10-.991-.098.498.498 0 00.991.098zM16.189 38.41a.498.498 0 100-.996.498.498 0 000 .996zM15.417 41.84a.498.498 0 100-.996.498.498 0 000 .997zM17.218 42.632a.498.498 0 100-.997.498.498 0 000 .997zM13.37 35.253a.498.498 0 100-.996.498.498 0 000 .996zM49.084 22.632a.498.498 0 10.617.781.498.498 0 00-.617-.781zM50.237 24.878a.497.497 0 10.782-.614.497.497 0 00-.782.614zM45.455 19.456a.498.498 0 10-.616-.781.498.498 0 00.616.781zM47.968 22.41a.498.498 0 10-.616-.78.498.498 0 00.616.78zM44.428 24.595a.498.498 0 10.616.781.498.498 0 00-.616-.781zM46.643 19.785a.498.498 0 10.616.781.498.498 0 00-.616-.781zM43.84 20.982a.497.497 0 10.781-.617.497.497 0 10-.781.617zM45.445 23.155a.498.498 0 10.617.782.498.498 0 00-.617-.782zM47.057 24.12a.497.497 0 10.781-.614.497.497 0 00-.781.614zM45.431 22.146a.497.497 0 10.782-.617.497.497 0 10-.782.617zM23.47 16.052a.498.498 0 10.997 0 .498.498 0 00-.996 0z" fill="#000"></path><path d="M32 9.223C16.56 9.223 4 19.44 4 32s12.56 22.777 28 22.777c15.438 0 27.998-10.217 27.998-22.777S47.438 9.223 32 9.223zm0 45.268C16.718 54.49 4.285 44.4 4.285 32 4.286 19.598 16.72 9.51 32 9.51c15.28 0 27.713 10.088 27.713 22.49S47.28 54.49 31.999 54.49z" fill="#000"></path><path d="M20.474 43.53c-.633 0-.633.982 0 .982s.633-.982 0-.982zM22.063 44.815c-.633 0-.633.982 0 .982s.633-.982 0-.982zM23.804 44.34c-.633 0-.633.982 0 .982s.633-.982 0-.982zM19.265 25.229c.633 0 .633-.982 0-.982s-.633.982 0 .982zM26.64 18.624c.634 0 .634-.982 0-.982-.632 0-.632.982 0 .982zM24.925 18.14c-.633 0-.633.982 0 .982s.633-.982 0-.982zM29.206 16.432c-.633 0-.633.982 0 .982s.633-.982 0-.982zM31.105 16.432c-.633 0-.633.982 0 .982s.633-.982 0-.982zM34.036 17.08c.633 0 .633-.982 0-.982s-.633.982 0 .982zM42.333 21.879c.633 0 .633-.982 0-.982s-.633.982 0 .982zM39.453 18.273c-.633 0-.633.982 0 .982s.633-.982 0-.982zM35.813 17.008c-.633 0-.633.982 0 .982s.633-.982 0-.982zM43.673 23.527c.633 0 .633-.982 0-.982s-.633.982 0 .982zM42.463 44.949c.633 0 .633-.982 0-.982s-.633.982 0 .982zM36.468 38.162a.498.498 0 100 .997.498.498 0 000-.997zM36.943 39.586a.498.498 0 100 .996.498.498 0 000-.996zM37.22 43.013a.498.498 0 10-.851-.517.498.498 0 00.851.517zM36.745 44.595a.498.498 0 10-.851-.517.498.498 0 00.851.517zM35.123 37.075a.498.498 0 10.851.517.498.498 0 00-.85-.517zM36.547 36.443a.498.498 0 10.851.516.498.498 0 00-.851-.516zM35.342 41.944c.633 0 .633-.983 0-.983s-.633.983 0 .983zM25.778 28.582a.498.498 0 10-.156.983.498.498 0 00.156-.983zM25.462 26.684a.498.498 0 10-.156.983.498.498 0 00.156-.983zM27.222 28.14a.498.498 0 100-.997.498.498 0 000 .996zM24.373 25.925a.498.498 0 100-.997.498.498 0 000 .997zM22.79 30.037a.498.498 0 100-.997.498.498 0 000 .997zM24.215 30.512a.498.498 0 100-.997.498.498 0 000 .997zM23.581 28.297a.498.498 0 10.001-.996.498.498 0 000 .996zM28.171 26.083a.498.498 0 100-.997.498.498 0 000 .997zM33.013 27.19a.498.498 0 100-.996.498.498 0 000 .996zM35.188 28.462a.498.498 0 100-.997.498.498 0 000 .997zM31.143 27.603a.498.498 0 100-.997.498.498 0 000 .997zM30.141 28.947a.498.498 0 100-.996.498.498 0 000 .996zM33.572 28.59a.498.498 0 10-.996 0 .498.498 0 00.996 0zM27.855 29.47a.498.498 0 10.996 0 .498.498 0 00-.996 0zM28.459 27.33a.498.498 0 10.997 0 .498.498 0 00-.997 0zM35.501 26.602a.498.498 0 100-.997.498.498 0 000 .997zM33.827 25.487a.498.498 0 100-.997.498.498 0 000 .997zM30.712 25.825a.498.498 0 100-.996.498.498 0 000 .996zM29.554 24.634a.498.498 0 10-.617-.78.498.498 0 00.617.78zM29.983 30.845a.498.498 0 100-.996.498.498 0 000 .996zM27.696 31.21a.498.498 0 10.997 0 .498.498 0 00-.997 0zM26.114 30.736a.498.498 0 10.997 0 .498.498 0 00-.997 0zM36.212 32.864a.497.497 0 10-.982-.156.497.497 0 00.982.156zM37.794 33.654a.498.498 0 10-.983-.155.498.498 0 00.983.155zM36.054 29.7a.497.497 0 10-.983-.156.497.497 0 00.983.156zM35.42 31.282a.498.498 0 10-.983-.156.498.498 0 00.983.156zM37.478 31.44a.498.498 0 10-.983-.155.498.498 0 00.983.155zM33.68 30.491a.498.498 0 10-.983-.156.498.498 0 00.983.156zM31.939 31.44a.498.498 0 10-.983-.156.498.498 0 00.983.156zM31.939 29.384a.498.498 0 10-.983-.156.498.498 0 00.983.156zM36.42 25.324a.498.498 0 10.157-.983.498.498 0 00-.156.983zM33.32 22.1a.498.498 0 10.001-.996.498.498 0 000 .997zM31.234 22.195a.498.498 0 10.997 0 .498.498 0 00-.997 0zM29.84 23.27a.498.498 0 100-.997.498.498 0 000 .996zM28.256 22.479a.498.498 0 100-.997.498.498 0 000 .997zM27.465 24.06a.498.498 0 100-.997.498.498 0 000 .997zM25.725 24.218a.498.498 0 100-.996.498.498 0 000 .996zM26.516 25.958a.498.498 0 100-.997.498.498 0 000 .997zM33.436 23.64a.498.498 0 100-.997.498.498 0 000 .996zM35.951 22.891a.498.498 0 10.997 0 .498.498 0 00-.997 0zM34.685 21.784a.498.498 0 10.996 0 .498.498 0 00-.996 0zM31.577 24.483a.498.498 0 10.156-.984.498.498 0 00-.156.984zM30.31 21.794a.498.498 0 10.156-.984.498.498 0 00-.156.984zM37.907 24.483a.498.498 0 10.156-.984.498.498 0 00-.156.984zM34.69 23.586a.498.498 0 10.983.155.498.498 0 00-.983-.155zM32.858 33.265a.498.498 0 10-.996 0 .498.498 0 00.996 0zM31.434 33.74a.498.498 0 10-.996 0 .498.498 0 00.997 0zM28.48 34.175a.498.498 0 00.517-.85.498.498 0 00-.517.85zM26.58 33.384a.498.498 0 00.518-.85.498.498 0 00-.517.85zM33.945 31.92a.498.498 0 00-.517.85.498.498 0 00.517-.85zM34.578 33.344a.498.498 0 00-.517.85.498.498 0 00.517-.85zM41.224 30.097a.5.5 0 10-.59-.805.5.5 0 00.59.805zM39.008 28.357a.5.5 0 10-.59-.805.5.5 0 00.59.805zM40.674 28.579a.5.5 0 10-.59-.806.5.5 0 00.59.806zM40.32 26.947a.5.5 0 10-.59-.806.5.5 0 00.59.806zM37.943 26.547a.5.5 0 00-.587-.806.5.5 0 00.587.806zM39.24 25.726a.5.5 0 10-.59-.806.5.5 0 00.59.806zM37.302 28.013a.497.497 0 10-.702-.704.497.497 0 00.702.704zM39.813 29.885a.497.497 0 10-.966.235.497.497 0 00.966-.235zM38.303 29.757a.497.497 0 10-.966.235.497.497 0 00.966-.235zM29.075 32.14c0 .632.983.632.983 0 0-.634-.983-.634-.983 0z" fill="#000"></path></svg><span>Listen to Podcasts and Articles</span></a></li></ul></div><div class="ExpandedNav_print__7d4vw" data-event-element="print edition"><h2 class="ExpandedNav_title__C8QcN ExpandedNav_printTitle__PKCL7">The Print Edition</h2><div class="ExpandedNav_printContainer__Lp_nj" data-action="magazine"><a href="/magazine/" data-action="cover" class="ExpandedNav_printImgLink__gcbdt"><img alt="" loading="lazy" class="Image_root__XxsOp Image_lazy__hYWHV ExpandedNav_printImg__hHeRU" src="https://www.theatlantic.com/magazine/images/current-issue.large.jpg" width="266" height="200"/></a><div class="ExpandedNav_printLinks__gNywy"><div class="ExpandedNav_topPrintLinks__UytSB"><a href="/magazine/" data-action="latest" class="ExpandedNav_latestIssue__iDXQm">Latest Issue</a><a href="/magazine/backissues/" data-action="past issues" class="ExpandedNav_pastIssues__nkE14">Past Issues</a></div><hr class="ExpandedNav_hr__5T2Ez"/><a href="https://accounts.theatlantic.com/products/gift" data-action="give a gift" class="ExpandedNav_giveAGift__vyp0c">Give a Gift</a></div></div></div></div></div></div></li><li class="Nav_navListItem__l2afO Nav_hideOnTablet__wyFPd Nav_searchLi__yxgD4"><button class="NavSearchButton_root__DcP_y" aria-label="Search The Atlantic" aria-expanded="false" aria-controls="nav-desktop-search" data-event-element="search icon" data-event-verb="opened" data-event-surface="search" data-event-module="search overlay"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 16 16" class="NavSearchButton_searchIcon__Acpm1" data-action="Open Search"><path d="M15.85 15.15l-5.27-5.28a6 6 0 10-.71.71l5.28 5.27a.48.48 0 00.7 0 .48.48 0 000-.7zM1 6a5 5 0 115 5 5 5 0 01-5-5z"></path></svg></button><div data-event-surface="search" data-event-module="search overlay" class="SearchOverlay_root__lmUcH" hidden="" id="nav-desktop-search"><div data-focus-guard="true" tabindex="0" style="width:1px;height:0px;padding:0;overflow:hidden;position:fixed;top:1px;left:1px"></div><div data-focus-lock-disabled="false" aria-modal="true" aria-labelledby="search-label" role="dialog"><form method="GET" action="/search/" class="SearchOverlay_searchForm___U0R_" data-action="search submit"><div class="SearchInput_root__6XLPB"><div class="VisuallyHidden_root__yoK4r"><label for="search-input-:R2srl2mm:">Search The Atlantic</label></div><button type="submit" title="Submit" class="SearchInput_searchButton__u0CP0"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 16 16" aria-hidden="true" width="20"><path d="M15.85 15.15l-5.27-5.28a6 6 0 10-.71.71l5.28 5.27a.48.48 0 00.7 0 .48.48 0 000-.7zM1 6a5 5 0 115 5 5 5 0 01-5-5z"></path></svg></button><input type="search" name="q" id="search-input-:R2srl2mm:" class="SearchInput_searchInput__5hWhI SearchInput_hideClear__re5AE" placeholder="Search The Atlantic..." autoComplete="off" required=""/></div><div class="QuickLinks_quickLinksContainer__F_iFd"><div class="QuickLinks_quickLinksHeading__ms7Ht">Quick Links</div><ul class="QuickLinks_quickLinksList__e7x66"><li class="QuickLinks_quickLinkListItem__59_09"><a class="QuickLinks_quickLink__w_Fp0" href="/projects/dear-therapist/" data-action="click link - quick link" data-label="Dear Therapist" data-event-element="quick link" data-event-position="1"><img alt="Dear Therapist" loading="lazy" class="Image_root__XxsOp Image_lazy__hYWHV QuickLinks_quickLinkImage__FTMBA" src="https://cdn.theatlantic.com/media/img/specialreports/lead/2020/10/14/Thumbnail.jpg" width="148" height="148"/><div class="QuickLinks_quickLinkLabel__TYtIC">Dear Therapist</div></a></li><li class="QuickLinks_quickLinkListItem__59_09"><a class="QuickLinks_quickLink__w_Fp0" href="/free-daily-crossword-puzzle/" data-action="click link - quick link" data-label="Crossword Puzzle" data-event-element="quick link" data-event-position="2"><img alt="Crossword Puzzle" loading="lazy" class="Image_root__XxsOp Image_lazy__hYWHV QuickLinks_quickLinkImage__FTMBA" src="https://cdn.theatlantic.com/assets/media/files/nav-crossword.png" width="148" height="148"/><div class="QuickLinks_quickLinkLabel__TYtIC">Crossword Puzzle</div></a></li><li class="QuickLinks_quickLinkListItem__59_09"><a class="QuickLinks_quickLink__w_Fp0" href="/archive/" data-action="click link - quick link" data-label="Magazine Archive" data-event-element="quick link" data-event-position="3"><img alt="Magazine Archive" loading="lazy" class="Image_root__XxsOp Image_lazy__hYWHV QuickLinks_quickLinkImage__FTMBA" src="https://cdn.theatlantic.com/media/files/archive-thumbnail.png" width="148" height="148"/><div class="QuickLinks_quickLinkLabel__TYtIC">Magazine Archive</div></a></li><li class="QuickLinks_quickLinkListItem__59_09"><a class="QuickLinks_quickLink__w_Fp0" href="https://accounts.theatlantic.com/accounts/subscription/" data-action="click link - quick link" data-label="Your Subscription" data-event-element="quick link" data-event-position="4"><img alt="Your Subscription" loading="lazy" class="Image_root__XxsOp Image_lazy__hYWHV QuickLinks_quickLinkImage__FTMBA" src="https://cdn.theatlantic.com/media/files/YourSubscription_300x300.jpg" width="148" height="148"/><div class="QuickLinks_quickLinkLabel__TYtIC">Your Subscription</div></a></li></ul></div><button type="button" aria-label="Close Search" class="SearchOverlay_closeButton___zntA" data-action="close search" data-event-verb="closed" data-event-element="close icon"><svg viewBox="0 0 16 16" xmlns="http://www.w3.org/2000/svg" class="SearchOverlay_closeIcon__DrMMb"><path d="M9.525 8l6.159 6.159a1.078 1.078 0 11-1.525 1.525L8 9.524l-6.159 6.16a1.076 1.076 0 01-1.525 0 1.078 1.078 0 010-1.525L6.476 8 .315 1.841A1.078 1.078 0 111.841.316L8 6.476l6.16-6.16a1.078 1.078 0 111.524 1.525L9.524 8z" fill-rule="evenodd"></path></svg></button></form></div><div data-focus-guard="true" tabindex="0" style="width:1px;height:0px;padding:0;overflow:hidden;position:fixed;top:1px;left:1px"></div></div></li><li class="Nav_navListItem__l2afO Nav_hideOnTablet__wyFPd"><a class="Nav_navLink__34Bol" href="/most-popular/" data-action="popular">Popular</a></li><li class="Nav_navListItem__l2afO Nav_hideOnTablet__wyFPd"><a class="Nav_navLink__34Bol" href="/latest/" data-action="latest">Latest</a></li><li class="Nav_navListItem__l2afO Nav_hideOnTablet__wyFPd"><a class="Nav_navLink__34Bol" href="/newsletters/" data-action="newsletters">Newsletters</a></li></ul><div aria-hidden="true" class="Nav_middleContainer__7JzLF" data-event-element="wordmark"><a href="/" class="Nav_hideAboveMobile__1lhmL Nav_mobileBigALink__eWXD_" tabindex="-1" data-action="big a"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 87.83 134" class="Nav_mobileBigA__9PTCs Nav_hideOnMobile__IESg8"><path d="M24.48 95.13c-.56 0-.74-.37-.74-.93l13.08-55.88c.19-.94.93-.94 1.12 0L50.09 94.2c0 .56-.19.93-.75.93zM48.22.19a22.54 22.54 0 01-7.66 5.05c-.75.19-.94.37-1.13 1.12l-26.72 112.5c-2 9-4.67 10.66-11.77 11.22a.88.88 0 00-.94.93v2.06a.88.88 0 00.92.93h25.6a.88.88 0 00.93-.93V131a.88.88 0 00-.93-.93c-9.53 0-10.47-2.81-8.6-10.66l4.49-19.25a1.18 1.18 0 011.12-.93h26.74a1.19 1.19 0 011.13.93l5 23.18c1.12 5-.75 6.17-7.1 6.73a.88.88 0 00-.93.93v2.06a.88.88 0 00.93.93h37.62a.88.88 0 00.94-.93V131a.88.88 0 00-.94-.93c-5.79-.56-8.22-1.5-9.34-6.73L49.34.57c-.19-.56-.75-.75-1.12-.38"></path></svg></a><a href="/" class="Nav_navLink__34Bol" tabindex="-1" data-action="logo"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 214 33.24" class="Nav_logo__RLN3C"><path d="M39.39 13.2c-2.4 0-4.43 1.82-7 5.32-1.18 1.64-2.7 4-3.37 5-.38.51-.68.43-.47-.12l1.78-4.56 6.36-17.5C37 .62 34.46-.25 34 .62v.09c-1.09 2.32-3.12 3.08-6.75 2.95S16.32 1.52 10.8 1.52C3.88 1.52 0 5.78 0 10.8c0 2.82 1.85 4.64 4.34 4.55a2.27 2.27 0 002.41-1.81 1.2 1.2 0 00-1.56-1.43c-2.45.51-3.29-1.18-3.29-2.49 0-3.12 2.66-5.44 8.22-5.44 1.43 0 4.22.34 7.17.67-3.75 11.3-7.55 21.77-8.48 24.25a2.07 2.07 0 01-1.35 1.44c-1.34.42-1.77.46-2.61.67-1.27.3-1.06 1.35-.17 1.31 1.6-.09 3.67-.3 5.31-.3 2 0 5.61.17 6.16.21 1 .09 1.14-1.14.3-1.26-.59-.09-1.56-.25-2.49-.38-1.1-.13-1.43-.59-1.18-1.48.55-1.47 7-20.11 8.27-24 2 .25 3.71.42 4.84.5 2.33.14 4.57 0 6.5-1.41l-5.1 14.4-4.47 12.33c-.76 2 2.1 2.15 2.74.93a81.64 81.64 0 017.63-12.36c1.86-2.7 3.59-4.31 4.81-4.31.93 0 1.47.51 1.47 1.65 0 1.52-.71 3.88-2.15 7.89-1.89 5.23-2.61 6.62-3.24 6.66s-1.86-1.52-2.53-1.69a1.39 1.39 0 00-1.65.72c-.34.59-.12 2.49 2.74 2.62 3.42.16 6.33-3.34 8.35-8.94 1.39-3.8 1.73-5.74 1.73-7.13 0-2.7-1.26-3.97-3.33-3.97zm57.9 18.09c-2.15-.5-3-1.3-3-2.15l.09-1.77c0-1.3 1-20.49 1.22-23.36.17-2.11-2.24-2-3.25-.76l-2 2.57C87.89 8.9 78 21.68 73.17 27.67A11.5 11.5 0 0168 31.25c-.8.21-.72 1.06.17 1.06.71 0 2.82-.25 4.38-.25s4.43.12 5.15.16 1-.76 0-1c-2-.59-3-1-3-1.52s.46-1.22 1.56-2.74c.84-1.18 2.86-3.84 5.1-6.79H91c-.21 4.05-.46 8.31-.5 9.15a1.14 1.14 0 01-.93 1.14l-2.15.63c-.59.17-.85 1.27.08 1.23 2.11-.13 3.88-.3 4.81-.3 1.39 0 3.75.3 4.85.34s.94-.85.13-1.07zm-6-15.47c0 .76-.09 1.6-.13 2.49h-8.25c3.84-5.07 7.89-10.38 8.23-10.89s.67-.25.63.13c-.13 1.86-.34 5.27-.5 8.27zM55.08 13.5c-3.67-.17-7.76 4.09-9.7 10.5-1.9 6.2.21 8.77 2.53 8.77 1.69 0 4.51-2.19 6.07-4.72.55-.89.13-1.82-.71-.89-1.06 1.14-2.49 2.36-4 2.07-1-.17-1.94-1.9-.46-6.2 3.54-.17 7.71-2.19 8.77-5.53.92-2.88-.98-3.96-2.5-4zm.38 3.12c-.89 2.61-4 4.8-6.24 5.35 2.15-5.69 4.21-7.21 5.52-7.17.72 0 1.06.82.72 1.82zm53.94-1h3.42c.76 0 1.14-.21 1.3-.76.3-.72.13-1.06-.63-1.06h-3.42l1.65-4.38c.21-.59 0-.89-.34-.89h-1.77c-.46 0-.63.13-.84.72L107 13.83h-2.7c-.38 0-.68-.08-.93 1.06-.09.55 0 .76.55.76h2.4l-4.09 10.67a45.64 45.64 0 00-1.69 4.68c-.25 1.48.64 2.07 1.73 1.86 2.15-.38 5.23-2.62 8-6.12.76-1 .13-1.64-.63-.84a34.4 34.4 0 01-3.67 3.16c-1.1.72-1.64.21-1.26-.84zm38.04-1c.25-.59-.59-.76-2.53-1.13-.59-.13-.93.5-1.94 2.61a4 4 0 00-3.5-1.43c-3.08.08-6.88 2.86-10 7.12-2.49 3.42-3.25 5.78-2.78 8.31a3.11 3.11 0 003.08 2.52c2.32.08 4.64-2.11 7-4.52l1.48-1.48c.42-.42.8-.17.54.34a23.77 23.77 0 00-1.89 4.17c-.3 1.48.5 1.86 1.64 1.69 2.19-.29 5.61-2.32 8.23-5.94.75-1.06 0-1.65-.68-.85a26.62 26.62 0 01-3.75 3.29c-1.14.76-1.65.55-1.31-.34.17-.55.8-2.07 6.41-14.36zm-9.74 11c-2.66 2.45-4.81 4.22-6.29 4.22-1 0-1.47-.43-1.56-1.14-.25-1.86 1.44-4.68 2.83-6.58 2.4-3.16 5.36-5.78 7.25-5.78 1.31 0 2 .55 2.11 1.35.25 1.46-2.19 5.93-4.34 7.87zm58.58-12.71c-2.07 0-4.85 1.47-7.47 4.38-.84 1-.21 1.65.59.93a20.28 20.28 0 012.87-2.19c.89-.55 1.48-.13 1.22.67-.21.64-.84 2.2-1.3 3.25l-2.87 6.58c-.8 1.86-1.56 3.71-1.73 4.22-.38 1.31.29 2 1.35 2 2 0 4.77-1.65 7.42-4.6.84-1 .21-1.64-.59-.93a28 28 0 01-3.12 2.4c-.88.54-1.52.12-1.22-.68.21-.59.84-1.94 1.26-2.91l2.91-6.58c.85-1.94 1.82-4 2-4.55.32-1.28-.31-1.99-1.32-1.99zm2.53-10.21a2.39 2.39 0 00-2.53 2.15 2.09 2.09 0 001.85 2.45 2.43 2.43 0 002.49-2.11 2.08 2.08 0 00-1.81-2.49zm11.68 10.84c-3.71-.17-7.68 4.13-9.62 10.46s.17 8.77 2.62 8.77c1.69 0 4.51-2 6.2-4.72.55-.89.13-1.82-.72-.89-1.05 1.14-2.4 2.19-3.79 2.11s-2.37-2-.76-6.62c2.36-6.66 4-7.42 4.72-7.47s2.19 1.86 3.08 2.07a1.36 1.36 0 001.64-.71c.38-.72.14-2.83-3.37-3zm-23.95.29h-3.42l1.64-4.38c.22-.59 0-.89-.33-.89h-1.78c-.46 0-.63.13-.84.72l-1.73 4.55h-2.74c-.38 0-.67-.08-.93 1.06-.08.55.05.76.55.76h2.41l-4.09 10.67a43.34 43.34 0 00-1.69 4.68c-.26 1.48.63 2.07 1.73 1.86 2.15-.38 5.23-2.62 8-6.12.76-1 .13-1.64-.64-.84a34.33 34.33 0 01-3.68 3.16c-1.1.72-1.65.21-1.27-.84l4.71-12.6h3.42c.76 0 1.14-.21 1.31-.76.29-.69.12-1.03-.63-1.03zm-63.6 11.9a40.24 40.24 0 01-3.8 3.33c-1.1.72-1.64.21-1.26-.84L128.17.97c.17-.42.08-1-.51-1a58.6 58.6 0 00-6 .68c-.34.08-.51.59-.13.71l2.28.85c.46.17.51.38.21 1.14l-8.84 22.97a43.34 43.34 0 00-1.69 4.68c-.25 1.48.63 2.07 1.73 1.86 2.28-.38 5.52-2.62 8.35-6.29.76-1.01.13-1.64-.63-.84zm43.39.08l2.49-5c1.35-2.74 1.61-4 1.61-4.93 0-1.81-.93-2.74-2.83-2.74-2.66 0-4.77 2.11-8 6.66-.89 1.22-1.48 2.15-2.66 3.67-.38.47-.67.42-.46-.13l1.64-4.09a17 17 0 001.35-4.47c0-1.09-.46-1.6-1.64-1.6-1.44 0-3.25.76-6.41 4.77-1.14 1.47 0 1.64.38 1.18.63-.64 2-2.07 2.91-2.87s1.72-.55 1.39.42a18.36 18.36 0 01-.8 2.24l-5 12.27c-.68 1.69 2.53 2.07 3.08.8 1.73-4 5.52-9 7.08-11.22 2.28-3.25 4.26-5.48 5.69-5.48.76 0 1.1.42 1.1 1.22a5.83 5.83 0 01-.59 2l-3.54 7.55c-1 2-1.94 4.13-2.11 4.68-.42 1.31.3 2 1.43 2 2 0 4.77-1.65 7.43-4.6.84-1 .21-1.64-.59-.93a29 29 0 01-3.12 2.41c-.92.59-1.56.12-1.26-.72.21-.6.97-2.16 1.43-3.09z"></path></svg></a></div><div class="Nav_rightContainer__CBCcP"><ul class="NavAccountLinks_root__8VKLM" data-event-element="account links"><li class="NavAccountLinks_navListItem__Lxooj"><a data-action="Sign In" href="https://accounts.theatlantic.com/login/" class="NavAccountLinks_navLink__ctd7M NavAccountLinks_hideOnMobile__Eokx4">Sign In</a></li><li class="NavAccountLinks_navListItem__Lxooj"><a data-action="Subscribe" href="https://www.theatlantic.com/subscribe/navbar/" class="NavAccountLinks_subscribe__2DNuJ">Subscribe</a></li></ul></div></div></div></nav><div class="Nav_fixedPosPlaceholder__0nyHE"></div><div class="Nav_overlay__zlKnQ" data-testid="overlay"></div><main id="main-content" data-category="story page" data-event-surface="article" data-flatplan-layout="standard"><gpt-ad class="GptAd_root__pAvcS Leaderboard_root__gbBIq" format="leaderboard" sizes-at-0="" sizes-at-976="leaderboard"></gpt-ad><article class="ArticleLayout_article__RHFMN article-content-body"><header class="ArticleHero_root__3w7kV ArticleHero_articleStandard__2tcdv" data-event-module="hero"><div class=""><div class="ArticleHero_defaultArticleLockup__vb8lz"><div class="ArticleHero_rubric__e4rjD"><div class="ArticleRubric_root__HNhbf" id="rubric" data-flatplan-rubric="true"><a class="ArticleRubric_link__nl9hy" href="https://www.theatlantic.com/health/" data-action="click link - section rubric" data-label="https://www.theatlantic.com/health/" data-event-element="rubric">Health</a></div></div><div class="ArticleHero_title__PQ4pC"><h1 class="ArticleTitle_root__VrZaG" data-flatplan-title="true">A Vaccine Reality Check</h1></div><div class="ArticleHero_dek__EqdkK" data-flatplan-description="true"><p class="ArticleDek_root__P3leE">So much hope is riding on a breakthrough, but a vaccine is only the beginning of the end.</p></div><div class="ArticleHero_byline__iFT6A"><div class="ArticleBylines_root__IBR5V"><address id="byline">By <a class="ArticleBylines_link__kNP4C" href="https://www.theatlantic.com/author/sarah-zhang/" data-action="click author - byline" data-label="https://www.theatlantic.com/author/sarah-zhang/" data-event-element="author" data-flatplan-author-link="true">Sarah Zhang</a></address></div></div></div><div class="ArticleLeadArt_root__nRSLU"><figure class="ArticleLeadFigure_root__Bj81R ArticleLeadFigure_standard__20Izv"><div class="ArticleLeadFigure_media__R1npW" data-flatplan-lead_figure_media="true"><picture><img alt="Illustration of praying hands, surrounded by syringes" class="Image_root__XxsOp ArticleLeadArt_image__HZS4B" sizes="(min-width: 976px) 976px, 100vw" srcSet="https://cdn.theatlantic.com/thumbor/cKLkauea62Nlf75LVVYCK4H9r5s=/0x0:2000x1125/750x422/media/img/mt/2020/07/vaccine/original.jpg 750w, https://cdn.theatlantic.com/thumbor/c4qgE2R4322aq0_K0NTdKQSrHLk=/0x0:2000x1125/828x466/media/img/mt/2020/07/vaccine/original.jpg 828w, https://cdn.theatlantic.com/thumbor/qK60q2VIyUzp6LkmcZ4UQd-UFLA=/0x0:2000x1125/960x540/media/img/mt/2020/07/vaccine/original.jpg 960w, https://cdn.theatlantic.com/thumbor/UdTFdSQJm09i7wMw092LNkJ7bfQ=/0x0:2000x1125/976x549/media/img/mt/2020/07/vaccine/original.jpg 976w, https://cdn.theatlantic.com/thumbor/u7u8OF_Iu9rFRkYl02ps9CxArhs=/0x0:2000x1125/1952x1098/media/img/mt/2020/07/vaccine/original.jpg 1952w" src="https://cdn.theatlantic.com/thumbor/qK60q2VIyUzp6LkmcZ4UQd-UFLA=/0x0:2000x1125/960x540/media/img/mt/2020/07/vaccine/original.jpg" id="article-lead-image" width="960" height="540"/></picture></div><figcaption class="ArticleLeadFigure_caption__Byu7W ArticleLeadFigure_standardCaption__PsDkd" data-flatplan-lead_figure_caption="true">The Atlantic</figcaption></figure></div></div><div class="ArticleHero_articleUtilityBar__JbQFj"><div class="ArticleHero_timestamp__bKhcB"><time class="ArticleTimestamp_root__b3bL6" dateTime="2020-07-24T14:12:42Z" data-flatplan-timestamp="true">July 24, 2020</time></div><div class="ArticleHero_articleUtilityBarTools__ZHw8s"><div class="ArticleShare_root__Mq0RB"><button class="ArticleShare_text__oQKBy ArticleShare_shareButton__X0cIe" aria-haspopup="true" aria-controls=":Rp2qoomm:" aria-expanded="false" aria-label="Open Share Menu" data-action="click share - expand" data-event-verb="shared" data-event-element="share dropdown">Share<svg width="15" height="15" fill="none" xmlns="http://www.w3.org/2000/svg" class="ArticleShare_shareIcon__G4iq1"><path fill-rule="evenodd" clip-rule="evenodd" d="M7.335.272a.25.25 0 01.337 0l4.623 4.204a.25.25 0 01.017.353l-.336.37a.25.25 0 01-.353.016L8.004 1.926v7.9a.25.25 0 01-.25.25h-.5a.25.25 0 01-.25-.25V1.924l-3.62 3.291a.25.25 0 01-.353-.016l-.336-.37a.25.25 0 01.016-.353L7.335.272zM.5 7.545a.25.25 0 00-.25.25v6.75c0 .138.112.25.25.25h14a.25.25 0 00.25-.25v-6.75a.25.25 0 00-.25-.25H14a.25.25 0 00-.25.25v6H1.25v-6a.25.25 0 00-.25-.25H.5z" fill="#000"></path></svg></button></div><button class="ArticleSave_text__PMSa1 ArticleSave_saveButton__96kFU">Save<!-- --> <svg width="12" height="16" fill="none" xmlns="http://www.w3.org/2000/svg" class="ArticleSaveIcon_icon__MuReP ArticleSaveIcon_unsaved___N_6I ArticleSave_bookmarkIcon__H5WvD"><path fill-rule="evenodd" clip-rule="evenodd" d="M6 10.828l5 3.31V1H1v13.139l5-3.31zM.776 15.486A.5.5 0 010 15.07V.5A.5.5 0 01.5 0h11a.5.5 0 01.5.5v14.57a.5.5 0 01-.776.416L6.138 12.12a.25.25 0 00-.276 0L.776 15.486z" fill="currentColor"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M5.572 8.75c0 .138.111.25.25.25h.5a.25.25 0 00.25-.25V6.57H8.75A.25.25 0 009 6.32v-.5a.25.25 0 00-.25-.25H6.572V3.25a.25.25 0 00-.25-.25h-.5a.25.25 0 00-.25.25v2.32H3.25a.25.25 0 00-.25.25v.5c0 .138.112.25.25.25h2.322v2.18z" fill="currentColor"></path></svg></button></div></div><gpt-ad class="GptAd_root__pAvcS ArticleInjector_root__I7x9v LeadArticleAd_root__tdCqm s-native s-native--standard s-native--streamline" format="injector" sizes-at-0="mobile-wide" targeting-pos="injector-article-start" sizes-at-976="desktop-wide"></gpt-ad><div class="ArticleInjector_clsAvoider__dqIAm" style="--placeholderHeight:298px"></div></header><section class="ArticleBody_root__2gF81" data-event-module="article body" data-flatplan-body="true"><p class="ArticleParagraph_root__4mszW ArticleParagraph_dropcap__uIVzg" data-flatplan-paragraph="true" data-flatplan-dropcap="true"><em><small>Updated at 7:56 p.m. on July 25, 2020.</small></em></p><p class="ArticleParagraph_root__4mszW ArticleParagraph_dropcap__uIVzg" data-flatplan-paragraph="true" data-flatplan-dropcap="true">N<span class="smallcaps">early five months</span> into the pandemic, all hopes of extinguishing COVID-19 are riding on a still-hypothetical vaccine. And so a refrain has caught on: We might have to stay home—until we have a vaccine. Close schools—until we have a vaccine. Wear masks—but only until we have a vaccine. During these months of misery, this mantra has offered a small glimmer of hope. Normal life is on the other side, and we just have to wait—until we have a vaccine.</p><div class="ArticleLegacyHtml_root__WFd2I ArticleLegacyHtml_paragraph__cY6a3 ArticleLegacyHtml_standard__kC_zi" style="background-color:#333;color:#fff;padding:12px 24px"><iframe class="lazyload" data-src="https://w.soundcloud.com/player/?url=https%3A//api.soundcloud.com/tracks/869401552%3Fsecret_token%3Ds-YbkigyvjltX&amp;inverse=true&amp;auto_play=false&amp;show_user=true" frameborder="no" height="20" scrolling="no" style="background-color: #333" title="embedded interactive content" width="100%"></iframe><i class="audm--download-cta">To hear more feature stories, <a href="https://www.audm.com/?utm_source=atl&amp;utm_medium=embed&amp;utm_campaign=vaccine_reality_check" style="color: #fff; text-decoration: underline;">get the Audm iPhone app.</a> </i></div><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">Feeding these hopes are the Trump administration’s exceedingly rosy projections of a <a data-event-element="inline link" href="https://www.hhs.gov/about/news/2020/05/21/trump-administration-accelerates-astrazeneca-covid-19-vaccine-to-be-available-beginning-in-october.html">vaccine as early as October</a>, as well as the media’s blow-by-blow coverage of vaccine trials. Each week brings news of “<a data-event-element="inline link" href="https://www.npr.org/2020/05/18/858444622/what-happened-today-drug-maker-reports-early-success-in-vaccine-trial">early success</a>,” “<a data-event-element="inline link" href="https://www.nytimes.com/2020/07/20/world/covid-coronavirus-vaccine.html">promising initial results</a>,” and stocks rising because of “<a data-event-element="inline link" href="https://www.marketwatch.com/story/stocks-open-mostly-higher-on-vaccine-optimism-2020-07-20">vaccine optimism</a>.” But a COVID-19 vaccine is unlikely to meet all of these high expectations. The vaccine probably won’t make the disease disappear. It certainly will not immediately return life to normal.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">Biologically, a vaccine against the COVID-19 virus is unlikely to offer complete protection. Logistically, manufacturers will have to make hundreds of millions of doses while relying, perhaps, on technology never before used in vaccines and competing for basic supplies such as glass vials. Then the federal government will have to allocate doses, perhaps through a patchwork of state and local health departments with no existing infrastructure for vaccinating adults at scale. The Centers for Disease Control and Prevention, which has led vaccine distribution efforts in the past, has been strikingly absent in discussions so far—a worrying sign that the leadership failures that have characterized the American pandemic could also hamper this process. To complicate it all, <a data-event-element="inline link" href="https://apnews.com/dacdc8bc428dd4df6511bfa259cfec44">20 percent of Americans</a> already say they will refuse to get a COVID-19 vaccine, and with another 31 percent unsure, reaching herd immunity could be that much more difficult.</p><p id="injected-recirculation-link-0" class="ArticleRelatedContentLink_root__VYc9V" data-view-action="view link - injected link - item 1" data-event-element="injected link" data-event-position="1"><a href="https://www.theatlantic.com/science/archive/2020/05/covid-19-vaccine-skeptics-conspiracies/611998/">Read: We don’t even have a COVID-19 vaccine, and yet the conspiracies are here</a></p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">The good news, because it is worth saying, is that experts think there will be a COVID-19 vaccine. The virus that causes COVID-19 does not seem to be an outlier like HIV. Scientists have gone from discovery of the virus to more than 165 candidate vaccines in record time, with <a data-event-element="inline link" href="https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html">27 vaccines already in human trials</a>. Human trials consist of at least three phases: Phase 1 for safety, Phase 2 for efficacy and dosing, and Phase 3 for efficacy in a huge group of tens of thousands of people. At least six COVID-19 vaccines are in or about to enter Phase 3 trials, which will take several more months.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">We are almost five months into the pandemic and <a data-event-element="inline link" href="https://www.nbcnews.com/health/health-news/fauci-covid-19-vaccine-we-will-least-have-answer-winter-n1233024">probably another five</a> from a safe and effective vaccine—assuming the clinical trials work out perfectly. “Even when a vaccine is introduced,” says Jesse Goodman, the former chief scientist at the Food and Drug Administration, “I think we will have several months of significant infection or at least risk of infection to look forward to.”</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">All of this means that we may have to endure more months under the threat of the coronavirus than we have already survived. Without the measures that have beat back the virus in much of Europe and Asia, there will continue to be more outbreaks, more school closings, more loneliness, more deaths ahead. A vaccine, when it is available, will mark only the beginning of a long, slow ramp down. And how long that ramp down takes will depend on the efficacy of a vaccine, the success in delivering hundreds of millions of doses, and the willingness of people to get it at all. It is awful to contemplate the suffering still ahead. It is easier to think about the promise of a vaccine.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">“There’s a lot of hope riding on these vaccines,” says <a data-event-element="inline link" href="https://www.doherty.edu.au/people/dr-kanta-subbarao">Kanta Subbarao</a>, the director of the World Health Organization’s flu collaborating center in Melbourne, who has also worked on other coronavirus vaccines. “Nobody wants to hear it’s not just right around the corner.”</p><p class="ArticleParagraph_root__4mszW ArticleParagraph_dropcap__uIVzg" data-flatplan-paragraph="true" data-flatplan-dropcap="true">V<span class="smallcaps">accines are</span>, in essence, a way to activate the immune system without disease. They can be made with weakened viruses, inactivated viruses, the proteins from a virus, a viral protein grafted onto an innocuous virus, or even just the mRNA that encodes a viral protein. Getting exposed to a vaccine is a bit like having survived the disease once, without the drawbacks. A lot remains unknown about the long-term immune response to COVID-19, but, <a data-event-element="inline link" href="https://www.theatlantic.com/ideas/archive/2020/07/could-covid-19-immunity-really-disappear-months/614377/">as my colleague Derek Thompson has explained</a>, there are good reasons to believe getting COVID-19 will protect against future infections in some way.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">Vaccine-induced immunity, though, tends to be weaker than immunity that arises after an infection. Vaccines are typically given as a shot straight into a muscle. Once your body recognizes the foreign invader, it mounts an immune response by, for example, producing long-lasting antibodies that circulate in the blood.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">But respiratory viruses don’t normally fling themselves into muscle. They infect respiratory systems, after all, and they usually sneak in through the mucous membranes of the nose and throat. Although vaccine shots induce antibodies in the blood, they don’t induce many in the mucous membranes, meaning they’re unlikely to prevent the virus from entering the body. But they could still protect tissues deeper in the body such as the lungs, thus keeping an infection from getting worse. “The primary benefit of vaccination will be to prevent severe disease,” says Subbarao. A COVID-19 vaccine is unlikely to achieve what scientists call “sterilizing immunity,” which prevents disease altogether.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">One way to boost the effectiveness of a respiratory-virus vaccine is to mimic a natural infection, by spraying live but weakened virus into the nose. FluMist, for example, contains weakened flu viruses, and <a data-event-element="inline link" href="https://www.nytimes.com/2020/07/14/health/coronavirus-nasal-vaccines.html">a handful of research groups</a> are looking into the strategy for COVID-19. But live virus vaccines are riskier because, well, the virus is live. “We don’t want to be spraying coronavirus up people’s noses until [we] are absolutely sure that it’s actually a virus that can’t spread from person to person and that it can’t make somebody sick,” says <a data-event-element="inline link" href="https://www.medschool.umaryland.edu/profiles/Neuzil-Kathleen/">Kathleen Neuzil</a>, the director of the University of Maryland’s Center for Vaccine Development and Global Health. “It will just take time.”</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">With this first generation of vaccines, though, speed is of the essence. An initial vaccine might limit COVID-19’s severity without entirely stopping its spread. Think flu shot, rather than polio vaccine. <a data-event-element="inline link" href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-action-help-facilitate-timely-development-safe-effective-covid">The FDA’s guidelines for a COVID-19</a> vaccine recognize it may be far from 100 percent effective; to win approval, the agency says, a vaccine should prevent or reduce severe disease in at least 50 percent of people who get it. “That’s obviously not ideal,” says <a data-event-element="inline link" href="https://vaccines.emory.edu/faculty-evc/primary-faculty/orenstein_walter.html">Walter Orenstein</a>, a vaccine researcher at Emory University who previously worked as the director of the National Immunization Program. “But it’s better than zero percent.”</p><p class="ArticleParagraph_root__4mszW ArticleParagraph_dropcap__uIVzg" data-flatplan-paragraph="true" data-flatplan-dropcap="true">I<span class="smallcaps">n recent weeks</span>, multiple vaccine groups have <a data-event-element="inline link" href="https://www.nytimes.com/2020/07/20/world/covid-coronavirus-vaccine.html">released promising data</a> that show their candidates can induce <a data-event-element="inline link" href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31605-6/fulltext">antibodies</a><a data-event-element="inline link" href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext"> that neutralize</a> <a data-event-element="inline link" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2022483">the coronavirus</a> <a data-event-element="inline link" href="https://www.medrxiv.org/content/10.1101/2020.06.30.20142570v1">in lab tests</a>. Their next challenges are about scale: testing the vaccine in a Phase 3 trial with tens of thousands of people to prove it prevents infection in the real world, and then, if it works, manufacturing hundreds of millions, even billions, of doses. This is why even a vaccine that has already been tested in small numbers of people is still many months away.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">Phase 3 trials are the largest and longest of the three phases—normally, they would take years, but they’re being compressed into months because of the pandemic. Still, vaccine makers need to enroll tens of thousands of people to confirm efficacy and to look for rare and long-term side effects. It will take time to recruit participants, time to wait for them to be naturally exposed to COVID-19, time for any long-term side effects to show up, and time to simply analyze all of the data.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">Perversely, the high and rising rates of COVID-19 in the United States do make it easier to test vaccine candidates here. Any given participant is more likely to get exposed to the virus at some point. “It’s not good news for our country in any way, shape, or form, but … it makes it possible to accumulate cases,” says <a data-event-element="inline link" href="https://www.jhsph.edu/faculty/directory/profile/360/ruth-karron">Ruth Karron</a>, the director of the Center for Immunization Research at Johns Hopkins University, who also served on the Data and Safety Monitoring Board for Moderna’s Phase 2 vaccine trial. Moderna, an American company, is conducting its Phase 3 trial in the U.S. A group based at the University of Oxford, which is collaborating with the U.K.-headquartered biotech company AstraZeneca, is running trials in Britain, Brazil, and South Africa—the latter two countries chosen specifically <a data-event-element="inline link" href="https://www.cbsnews.com/news/coronavirus-vaccine-trial-oxford-expands-south-africa-brazil/">because of their high numbers of COVID-19 cases</a><a data-event-element="inline link" id="corrected" name="corrected">.</a><a data-event-element="inline link" href="#correction">*</a></p><p id="injected-recirculation-link-1" class="ArticleRelatedContentLink_root__VYc9V" data-view-action="view link - injected link - item 2" data-event-element="injected link" data-event-position="2"><a href="https://www.theatlantic.com/photo/2020/05/photos-coronavirus-brazil/611608/">Photos: The coronavirus in Brazil</a></p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">In the U.S., the Trump administration’s <a data-event-element="inline link" href="https://www.hhs.gov/about/news/2020/06/16/fact-sheet-explaining-operation-warp-speed.html">Operation Warp Speed</a> is helping several vaccine makers invest in manufacturing facilities while these trials are ongoing. This could reduce the lag time between the approval and the availability of a vaccine, since companies might otherwise wait for FDA approval before scaling up manufacturing. But making hundreds of millions of doses is still a considerable challenge, especially for a novel vaccine.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">The leading COVID-19 vaccine candidates rely on technology that’s never been used before in approved vaccines. Moderna’s vaccine, for example, is a piece of RNA that encodes a coronavirus protein. Oxford and AstraZeneca’s vaccine attaches a coronavirus protein to a chimpanzee adenovirus. Neither has been manufactured before on the necessary scale.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">Consider what happened in 2009, the most recent time the world mobilized to produce vaccines to stop a pandemic. The disease was H1N1, more commonly known as the “swine flu,” and vaccine makers had the much simpler task of subbing the H1N1 strain into the seasonal flu vaccine they make every year. Despite many, many years of experience in making flu vaccines, the manufacturers hit an unexpected snag. Most flu vaccines are made from viruses grown in chicken eggs, and for some reason, the <a data-event-element="inline link" href="https://www.cidrap.umn.edu/news-perspective/2009/10/us-h1n1-vaccine-delayed-cases-and-deaths-rise">H1N1 strain did not grow very well in the eggs at first</a>. “The amounts produced from a given amount of eggs were much lower than normal,” says Goodman, who led the FDA’s pandemic response in 2009. “So that really delayed things.” Then, once millions of doses were in the works, Goodman says, there weren’t enough facilities that could package the bulk vaccine into individual vials.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">The Department of Health and Human Services created a network of <a data-event-element="inline link" href="https://www.medicalcountermeasures.gov/barda/core-services/fill-finish-manufacturing-network/">fill-and-finish facilities</a> to address this problem in the future. Right now, Operation Warp Speed is <a data-event-element="inline link" href="https://www.hhs.gov/sites/default/files/fact-sheet-operation-warp-speed.pdf">also awarding contracts</a> to make the millions of syringes and glass vials needed to package a COVID-19 vaccine. Without careful planning on these fronts, the U.S. could run into a demoralizing scenario where vaccines are available, but there is no way to physically get them to people.</p><p class="ArticleParagraph_root__4mszW ArticleParagraph_dropcap__uIVzg" data-flatplan-paragraph="true" data-flatplan-dropcap="true">E<span class="smallcaps">ven if all</span> of this goes well—the earliest candidates are effective, the trials conclude quickly, the technology works—another huge task lies ahead: When vaccines are approved, 300 million doses will not be available all at once, and a system is needed to distribute limited supplies to the public. This is exactly the sort of challenge that the U.S. government has proved unprepared for in this pandemic.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">In the H1N1 pandemic, the U.S. government purchased the vaccines and allocated doses to state and local health departments, which in turn vaccinated people through mass clinics as well as employers, schools, hospitals, pharmacies, and doctor’s offices. Nationwide, the program eventually vaccinated about <a data-event-element="inline link" href="https://www.cidrap.umn.edu/news-perspective/2010/04/cdc-estimates-24-americans-received-h1n1-vaccine">a quarter of all Americans</a>—demand fell because the pandemic itself peaked not long after the vaccine became available.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">The 2009 vaccination program was built on the infrastructure of the <a data-event-element="inline link" href="https://www.cdc.gov/H1N1flu/vaccination/statelocal/centralized_distribution_qa.htm">Vaccines for Children Program</a>, in which the CDC buys and distributes vaccines to states for children who usually are uninsured or on Medicaid. Immunization managers who work in these programs are well versed in the intricacies of vaccine storage and distribution, such as maintaining a cold chain for vaccines that could become ineffective at room temperature. But because they work with children’s vaccines, they deal mostly with pediatrician’s offices. “We didn’t have relationships with hospitals and internists and people who vaccinated adults,” says <a data-event-element="inline link" href="https://www.vumc.org/health-policy/person/kelly-l-moore-md-mph">Kelly Moore</a>, who was the director of the Tennessee Immunization Program in 2009. In August that year, two months before they got their first shipment of the vaccine, Moore’s team created a sign-up on the state immunization registry and sent out a newsletter every Friday with updates and training modules for handling vaccines.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">“Unfortunately,” says Moore, “that network has not been maintained because we haven’t had other vaccines to send them in 11 years.” Contact information is out of date. Rebuilding this network for adults will be even more important with COVID-19. Although the H1N1 vaccine was recommended for all ages, the focus was on kids, for whom the flu was particularly dangerous. The opposite is true of COVID-19, which is more of a threat to older adults.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">Some of the leading COVID-19 vaccine candidates could also pose new logistical challenges, if they require storage at <a data-event-element="inline link" href="https://www.reuters.com/article/us-health-coronavirus-vaccines-manufactu/vaccine-makers-face-biggest-medical-manufacturing-challenge-in-history-idUSKBN23W1ND">temperatures as low as –80 degrees Celsius</a> or multiple doses to be effective. In fact, a COVID-19 vaccine is quite likely to <a data-event-element="inline link" href="https://www.bloomberg.com/news/articles/2020-07-20/double-shot-covid-vaccine-tests-raise-new-pandemic-challenge">require two doses</a>; the first primes the immune system, allowing the second to induce a stronger immune response. Officials would have to balance giving one dose to as many people as possible with giving a second dose to those who already had one. “That was a complication we didn’t face in 2009, and we were so grateful,” says Moore.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">Although the CDC took the lead in distributing H1N1 vaccines in 2009, Claire Hannan, the executive director of the Association of Immunization Managers, says the agency has been oddly silent about plans for a COVID-19 vaccine since April. “Initially, we were having planning calls with CDC right away,” she says. “And then nothing.” She has unsuccessfully tried to get in touch with Operation Warp Speed, which <a data-event-element="inline link" href="https://www.hhs.gov/about/news/2020/06/16/fact-sheet-explaining-operation-warp-speed.html">has suggested the Department of Defense</a> may also get involved in vaccine distribution. “We continue to ask CDC these many, many questions. And they don’t know,” she says.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">The CDC’s Advisory Committee on Immunization Practices is also normally responsible for recommendations on how to prioritize vaccines. The committee, which is composed of outside experts, last met in late June, when they <a data-event-element="inline link" href="https://www.sciencemag.org/news/2020/06/line-forming-covid-19-vaccine-who-should-be-front">discussed prioritizing vaccines</a> for health-care workers, the elderly, and those with underlying conditions. They also considered prioritizing vaccination by race, given the <a data-event-element="inline link" href="https://www.theatlantic.com/ideas/archive/2020/04/coronavirus-exposing-our-racial-divides/609526/">racial disparities in COVID-19 cases</a>. But now the National Academy of Medicine is convening a panel on the same topic, which is <a data-event-element="inline link" href="https://www.statnews.com/2020/07/22/confusion-spreads-over-system-to-determine-priority-access-to-covid-19-vaccines/">again causing confusion</a> about who is responsible for making these decisions.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">In 2009, Moore’s job was to put the CDC advisory committee’s recommendations into practice. Two or three times a week, she would get an email from the CDC’s vaccine distributor letting her know the number of doses available for her entire state. In practice, though, an initial shipment of vaccines might not be enough to cover everyone in even the highest priority group, such as health-care workers. It was up to people like Moore to decide which hospital got how many doses, with the promise of more on the way next week. Then individual hospitals administered the actual vaccines to their employees based on priority status.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">This system is meant to be flexible and responsive to local conditions, but it also means the availability of a vaccine might seem to vary from place to place. For example, <a data-event-element="inline link" href="https://www.txstate.edu/anthropology/people/faculty/brunson.html">Emily Brunson</a>, an anthropologist at Texas State University who studies vaccines, says that in 2009 there were cases in which one district interpreted recommendations strictly, giving the vaccine only to high-priority groups, and a neighboring district offered it to anyone who wanted it. The decision to distribute the vaccine through employee health centers in New York, which happened to include several Wall Street firms, <a data-event-element="inline link" href="https://www.cnbc.com/id/33655723">also caused a big backlash</a>. “There are many ways that things can be misinterpreted,” Brunson says. And during an initial shortage, these decisions can feel unfair—especially given tensions seeded earlier in the pandemic when <a data-event-element="inline link" href="https://www.theatlantic.com/politics/archive/2020/03/coronavirus-testing-rich-people/608062/">the rich and the famous were getting COVID-19</a> tests while ordinary people were being turned away at clinics.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">If the pandemic so far is any indication, a vaccination program is likely to take place against a backdrop of partisanship and misinformation. Already, <a data-event-element="inline link" href="https://www.bbc.com/news/52847648">conspiracy theories are spreading about a COVID-19 vaccine</a>, some of them downright outlandish. But the emphasis on speed—as in “Operation <em>Warp Speed</em>”—has also created real worries about vaccines being rushed to market. At a congressional hearing with five vaccine makers on Tuesday, company officials had to <a data-event-element="inline link" href="https://www.statnews.com/2020/07/21/pharma-promises-cut-corners-covid-19-vaccine/">repeatedly push back against the idea that the industry might cut corners</a> for a COVID-19 vaccine.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">“We’re going to be in a situation where some people will be desperate to get the vaccine and some people will be afraid to get the vaccine. And there’ll be probably a lot of people in between who are a little bit of both or not sure,” says <a data-event-element="inline link" href="https://gufaculty360.georgetown.edu/s/contact/00336000014RdeeAAC/michael-stoto">Michael Stoto</a>, a public-health researcher at Georgetown University. A vaccine, especially a novel one that doesn’t offer complete protection against COVID-19, will require careful communication about risk. “The fact that we can’t get ourselves straight about wearing masks will make that harder,” he adds. Given the number of Americans who are currently unsure of or opposed to getting a COVID-19 vaccine, Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, <a data-event-element="inline link" href="https://www.cnn.com/2020/06/28/health/fauci-coronavirus-vaccine-contact-tracing-aspen/index.html">has warned</a> that even a vaccine might not get the country to herd immunity if too many people refuse it.</p><p id="injected-recirculation-link-2" class="ArticleRelatedContentLink_root__VYc9V" data-view-action="view link - injected link - item 3" data-event-element="injected link" data-event-position="3"><a href="https://www.theatlantic.com/health/archive/2020/07/herd-immunity-coronavirus/614035/">Read: A new understanding of herd immunity</a></p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">For the Americans pinning their hopes on a vaccine, a botched rollout could feel like yet another example of failure in the time of COVID-19. That could have disastrous consequences that last well beyond the pandemic itself. Brunson worries that such a scenario could undermine trust in public-health expertise and in all vaccines. “Both of those would be disasters,” she says, “in addition to the COVID itself being a disaster.” It could mean, for example, further resurgences of vaccine-preventable diseases such as measles and an even bigger challenge when battling future pandemics.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true">For all the uncertainties that remain ahead for a COVID-19 vaccine, several experts were willing to make one prediction. “I think the question that is easy to answer is, ‘Is this virus going to go away?’ And the answer to that is, ‘<em>No</em>,’” says Karron, the vaccine expert at Johns Hopkins. The virus is already too widespread. A vaccine could still mitigate severe cases; it could make COVID-19 easier to live with. The virus is likely here to stay, but eventually, the pandemic will end.</p><p class="ArticleParagraph_root__4mszW" data-flatplan-paragraph="true"><small><em><a data-event-element="inline link" id="correction" name="correction"></a><a data-event-element="inline link" href="#corrected">*</a>This piece originally identified AstraZeneca as a British-Swiss biotech company.</em></small></p><div class="ArticleBody_divider__GpNxD" id="article-end"></div></section><div data-event-module="footer"><div class="ArticleWell_root__fueCa"><div><address id="article-writer-0" class="ArticleBio_root__ua8zj" data-event-element="author" data-flatplan-bio="true"><div class="ArticleBio_content__O0ZVF"><div class="ArticleBio_bio__DXQnd" data-flatplan-bio="true"><a href="https://www.theatlantic.com/author/sarah-zhang/" class="author-link" data-label="https://www.theatlantic.com/author/sarah-zhang/" data-action="click author - name"  >Sarah Zhang</a> is a staff writer at <em>The Atlantic.</em></div></div></address></div></div><div></div></div><gpt-ad class="GptAd_root__pAvcS ArticleInjector_root__I7x9v s-native s-native--standard s-native--streamline" format="injector" sizes-at-0="mobile-wide,native,house" targeting-pos="injector-most-popular" sizes-at-976="desktop-wide,native,house"></gpt-ad><div class="ArticleInjector_clsAvoider__dqIAm"></div></article><div></div></main><div></div><div></div></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"isLoggedIn":false,"hasPaywallAccess":false,"hasAdFree":false,"pageProps":{"id":"BlogArticle:614566","isTnfCompatible":true,"layout":"standard","hasMeter":true,"url":"https://www.theatlantic.com/health/archive/2020/07/covid-19-vaccine-reality-check/614566/","dateModified":"2021-02-23T18:53:59Z","__typename":"BlogArticle","notFound":false,"urqlState":{"1274462967":{"data":"{\"article\":{\"__typename\":\"BlogArticle\",\"id\":\"BlogArticle:614566\",\"categories\":[{\"slug\":\"coronavirus-covid-19\",\"__typename\":\"Category\"},{\"slug\":\"corrections\",\"__typename\":\"Category\"}],\"content\":[{\"__typename\":\"ArticleParagraphContent\",\"subtype\":\"DROPCAP\",\"idAttr\":\"\",\"innerHtml\":\"\u003cem\u003e\u003csmall\u003eUpdated at 7:56 p.m. on July 25, 2020.\u003c/small\u003e\u003c/em\u003e\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":\"DROPCAP\",\"idAttr\":\"\",\"innerHtml\":\"N\u003cspan class=\\\"smallcaps\\\"\u003eearly five months\u003c/span\u003e into the pandemic, all hopes of extinguishing COVID-19 are riding on a still-hypothetical vaccine. And so a refrain has caught on: We might have to stay home—until we have a vaccine. Close schools—until we have a vaccine. Wear masks—but only until we have a vaccine. During these months of misery, this mantra has offered a small glimmer of hope. Normal life is on the other side, and we just have to wait—until we have a vaccine.\"},{\"__typename\":\"ArticleLegacyHtml\",\"tagName\":\"P\",\"idAttr\":\"\",\"className\":\"\",\"style\":\"background-color: #333; color: #fff; padding: 12px 24px;\",\"innerHtml\":\"\u003ciframe class=\\\"lazyload\\\" data-src=\\\"https://w.soundcloud.com/player/?url=https%3A//api.soundcloud.com/tracks/869401552%3Fsecret_token%3Ds-YbkigyvjltX\u0026amp;inverse=true\u0026amp;auto_play=false\u0026amp;show_user=true\\\" frameborder=\\\"no\\\" height=\\\"20\\\" scrolling=\\\"no\\\" style=\\\"background-color: #333\\\" title=\\\"embedded interactive content\\\" width=\\\"100%\\\"\u003e\u003c/iframe\u003e\u003ci class=\\\"audm--download-cta\\\"\u003eTo hear more feature stories, \u003ca href=\\\"https://www.audm.com/?utm_source=atl\u0026amp;utm_medium=embed\u0026amp;utm_campaign=vaccine_reality_check\\\" style=\\\"color: #fff; text-decoration: underline;\\\"\u003eget the Audm iPhone app.\u003c/a\u003e \u003c/i\u003e\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"Feeding these hopes are the Trump administration’s exceedingly rosy projections of a \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.hhs.gov/about/news/2020/05/21/trump-administration-accelerates-astrazeneca-covid-19-vaccine-to-be-available-beginning-in-october.html\\\"\u003evaccine as early as October\u003c/a\u003e, as well as the media’s blow-by-blow coverage of vaccine trials. Each week brings news of “\u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.npr.org/2020/05/18/858444622/what-happened-today-drug-maker-reports-early-success-in-vaccine-trial\\\"\u003eearly success\u003c/a\u003e,” “\u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.nytimes.com/2020/07/20/world/covid-coronavirus-vaccine.html\\\"\u003epromising initial results\u003c/a\u003e,” and stocks rising because of “\u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.marketwatch.com/story/stocks-open-mostly-higher-on-vaccine-optimism-2020-07-20\\\"\u003evaccine optimism\u003c/a\u003e.” But a COVID-19 vaccine is unlikely to meet all of these high expectations. The vaccine probably won’t make the disease disappear. It certainly will not immediately return life to normal.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"Biologically, a vaccine against the COVID-19 virus is unlikely to offer complete protection. Logistically, manufacturers will have to make hundreds of millions of doses while relying, perhaps, on technology never before used in vaccines and competing for basic supplies such as glass vials. Then the federal government will have to allocate doses, perhaps through a patchwork of state and local health departments with no existing infrastructure for vaccinating adults at scale. The Centers for Disease Control and Prevention, which has led vaccine distribution efforts in the past, has been strikingly absent in discussions so far—a worrying sign that the leadership failures that have characterized the American pandemic could also hamper this process. To complicate it all, \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://apnews.com/dacdc8bc428dd4df6511bfa259cfec44\\\"\u003e20 percent of Americans\u003c/a\u003e already say they will refuse to get a COVID-19 vaccine, and with another 31 percent unsure, reaching herd immunity could be that much more difficult.\"},{\"__typename\":\"ArticleRelatedContentLink\",\"idAttr\":\"injected-recirculation-link-0\",\"innerHtml\":\"\u003ca href=\\\"https://www.theatlantic.com/science/archive/2020/05/covid-19-vaccine-skeptics-conspiracies/611998/\\\"\u003eRead: We don’t even have a COVID-19 vaccine, and yet the conspiracies are here\u003c/a\u003e\",\"index\":0},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"The good news, because it is worth saying, is that experts think there will be a COVID-19 vaccine. The virus that causes COVID-19 does not seem to be an outlier like HIV. Scientists have gone from discovery of the virus to more than 165 candidate vaccines in record time, with \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html\\\"\u003e27 vaccines already in human trials\u003c/a\u003e. Human trials consist of at least three phases: Phase 1 for safety, Phase 2 for efficacy and dosing, and Phase 3 for efficacy in a huge group of tens of thousands of people. At least six COVID-19 vaccines are in or about to enter Phase 3 trials, which will take several more months.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"We are almost five months into the pandemic and \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.nbcnews.com/health/health-news/fauci-covid-19-vaccine-we-will-least-have-answer-winter-n1233024\\\"\u003eprobably another five\u003c/a\u003e from a safe and effective vaccine—assuming the clinical trials work out perfectly. “Even when a vaccine is introduced,” says Jesse Goodman, the former chief scientist at the Food and Drug Administration, “I think we will have several months of significant infection or at least risk of infection to look forward to.”\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"All of this means that we may have to endure more months under the threat of the coronavirus than we have already survived. Without the measures that have beat back the virus in much of Europe and Asia, there will continue to be more outbreaks, more school closings, more loneliness, more deaths ahead. A vaccine, when it is available, will mark only the beginning of a long, slow ramp down. And how long that ramp down takes will depend on the efficacy of a vaccine, the success in delivering hundreds of millions of doses, and the willingness of people to get it at all. It is awful to contemplate the suffering still ahead. It is easier to think about the promise of a vaccine.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"“There’s a lot of hope riding on these vaccines,” says \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.doherty.edu.au/people/dr-kanta-subbarao\\\"\u003eKanta Subbarao\u003c/a\u003e, the director of the World Health Organization’s flu collaborating center in Melbourne, who has also worked on other coronavirus vaccines. “Nobody wants to hear it’s not just right around the corner.”\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":\"DROPCAP\",\"idAttr\":\"\",\"innerHtml\":\"V\u003cspan class=\\\"smallcaps\\\"\u003eaccines are\u003c/span\u003e, in essence, a way to activate the immune system without disease. They can be made with weakened viruses, inactivated viruses, the proteins from a virus, a viral protein grafted onto an innocuous virus, or even just the mRNA that encodes a viral protein. Getting exposed to a vaccine is a bit like having survived the disease once, without the drawbacks. A lot remains unknown about the long-term immune response to COVID-19, but, \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.theatlantic.com/ideas/archive/2020/07/could-covid-19-immunity-really-disappear-months/614377/\\\"\u003eas my colleague Derek Thompson has explained\u003c/a\u003e, there are good reasons to believe getting COVID-19 will protect against future infections in some way.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"Vaccine-induced immunity, though, tends to be weaker than immunity that arises after an infection. Vaccines are typically given as a shot straight into a muscle. Once your body recognizes the foreign invader, it mounts an immune response by, for example, producing long-lasting antibodies that circulate in the blood.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"But respiratory viruses don’t normally fling themselves into muscle. They infect respiratory systems, after all, and they usually sneak in through the mucous membranes of the nose and throat. Although vaccine shots induce antibodies in the blood, they don’t induce many in the mucous membranes, meaning they’re unlikely to prevent the virus from entering the body. But they could still protect tissues deeper in the body such as the lungs, thus keeping an infection from getting worse. “The primary benefit of vaccination will be to prevent severe disease,” says Subbarao. A COVID-19 vaccine is unlikely to achieve what scientists call “sterilizing immunity,” which prevents disease altogether.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"One way to boost the effectiveness of a respiratory-virus vaccine is to mimic a natural infection, by spraying live but weakened virus into the nose. FluMist, for example, contains weakened flu viruses, and \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.nytimes.com/2020/07/14/health/coronavirus-nasal-vaccines.html\\\"\u003ea handful of research groups\u003c/a\u003e are looking into the strategy for COVID-19. But live virus vaccines are riskier because, well, the virus is live. “We don’t want to be spraying coronavirus up people’s noses until [we] are absolutely sure that it’s actually a virus that can’t spread from person to person and that it can’t make somebody sick,” says \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.medschool.umaryland.edu/profiles/Neuzil-Kathleen/\\\"\u003eKathleen Neuzil\u003c/a\u003e, the director of the University of Maryland’s Center for Vaccine Development and Global Health. “It will just take time.”\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"With this first generation of vaccines, though, speed is of the essence. An initial vaccine might limit COVID-19’s severity without entirely stopping its spread. Think flu shot, rather than polio vaccine. \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-action-help-facilitate-timely-development-safe-effective-covid\\\"\u003eThe FDA’s guidelines for a COVID-19\u003c/a\u003e vaccine recognize it may be far from 100 percent effective; to win approval, the agency says, a vaccine should prevent or reduce severe disease in at least 50 percent of people who get it. “That’s obviously not ideal,” says \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://vaccines.emory.edu/faculty-evc/primary-faculty/orenstein_walter.html\\\"\u003eWalter Orenstein\u003c/a\u003e, a vaccine researcher at Emory University who previously worked as the director of the National Immunization Program. “But it’s better than zero percent.”\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":\"DROPCAP\",\"idAttr\":\"\",\"innerHtml\":\"I\u003cspan class=\\\"smallcaps\\\"\u003en recent weeks\u003c/span\u003e, multiple vaccine groups have \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.nytimes.com/2020/07/20/world/covid-coronavirus-vaccine.html\\\"\u003ereleased promising data\u003c/a\u003e that show their candidates can induce \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31605-6/fulltext\\\"\u003eantibodies\u003c/a\u003e\u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext\\\"\u003e that neutralize\u003c/a\u003e \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.nejm.org/doi/full/10.1056/NEJMoa2022483\\\"\u003ethe coronavirus\u003c/a\u003e \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.medrxiv.org/content/10.1101/2020.06.30.20142570v1\\\"\u003ein lab tests\u003c/a\u003e. Their next challenges are about scale: testing the vaccine in a Phase 3 trial with tens of thousands of people to prove it prevents infection in the real world, and then, if it works, manufacturing hundreds of millions, even billions, of doses. This is why even a vaccine that has already been tested in small numbers of people is still many months away.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"Phase 3 trials are the largest and longest of the three phases—normally, they would take years, but they’re being compressed into months because of the pandemic. Still, vaccine makers need to enroll tens of thousands of people to confirm efficacy and to look for rare and long-term side effects. It will take time to recruit participants, time to wait for them to be naturally exposed to COVID-19, time for any long-term side effects to show up, and time to simply analyze all of the data.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"Perversely, the high and rising rates of COVID-19 in the United States do make it easier to test vaccine candidates here. Any given participant is more likely to get exposed to the virus at some point. “It’s not good news for our country in any way, shape, or form, but … it makes it possible to accumulate cases,” says \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.jhsph.edu/faculty/directory/profile/360/ruth-karron\\\"\u003eRuth Karron\u003c/a\u003e, the director of the Center for Immunization Research at Johns Hopkins University, who also served on the Data and Safety Monitoring Board for Moderna’s Phase 2 vaccine trial. Moderna, an American company, is conducting its Phase 3 trial in the U.S. A group based at the University of Oxford, which is collaborating with the U.K.-headquartered biotech company AstraZeneca, is running trials in Britain, Brazil, and South Africa—the latter two countries chosen specifically \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.cbsnews.com/news/coronavirus-vaccine-trial-oxford-expands-south-africa-brazil/\\\"\u003ebecause of their high numbers of COVID-19 cases\u003c/a\u003e\u003ca data-event-element=\\\"inline link\\\" id=\\\"corrected\\\" name=\\\"corrected\\\"\u003e.\u003c/a\u003e\u003ca data-event-element=\\\"inline link\\\" href=\\\"#correction\\\"\u003e*\u003c/a\u003e\"},{\"__typename\":\"ArticleRelatedContentLink\",\"idAttr\":\"injected-recirculation-link-1\",\"innerHtml\":\"\u003ca href=\\\"https://www.theatlantic.com/photo/2020/05/photos-coronavirus-brazil/611608/\\\"\u003ePhotos: The coronavirus in Brazil\u003c/a\u003e\",\"index\":1},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"In the U.S., the Trump administration’s \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.hhs.gov/about/news/2020/06/16/fact-sheet-explaining-operation-warp-speed.html\\\"\u003eOperation Warp Speed\u003c/a\u003e is helping several vaccine makers invest in manufacturing facilities while these trials are ongoing. This could reduce the lag time between the approval and the availability of a vaccine, since companies might otherwise wait for FDA approval before scaling up manufacturing. But making hundreds of millions of doses is still a considerable challenge, especially for a novel vaccine.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"The leading COVID-19 vaccine candidates rely on technology that’s never been used before in approved vaccines. Moderna’s vaccine, for example, is a piece of RNA that encodes a coronavirus protein. Oxford and AstraZeneca’s vaccine attaches a coronavirus protein to a chimpanzee adenovirus. Neither has been manufactured before on the necessary scale.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"Consider what happened in 2009, the most recent time the world mobilized to produce vaccines to stop a pandemic. The disease was H1N1, more commonly known as the “swine flu,” and vaccine makers had the much simpler task of subbing the H1N1 strain into the seasonal flu vaccine they make every year. Despite many, many years of experience in making flu vaccines, the manufacturers hit an unexpected snag. Most flu vaccines are made from viruses grown in chicken eggs, and for some reason, the \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.cidrap.umn.edu/news-perspective/2009/10/us-h1n1-vaccine-delayed-cases-and-deaths-rise\\\"\u003eH1N1 strain did not grow very well in the eggs at first\u003c/a\u003e. “The amounts produced from a given amount of eggs were much lower than normal,” says Goodman, who led the FDA’s pandemic response in 2009. “So that really delayed things.” Then, once millions of doses were in the works, Goodman says, there weren’t enough facilities that could package the bulk vaccine into individual vials.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"The Department of Health and Human Services created a network of \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.medicalcountermeasures.gov/barda/core-services/fill-finish-manufacturing-network/\\\"\u003efill-and-finish facilities\u003c/a\u003e to address this problem in the future. Right now, Operation Warp Speed is \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.hhs.gov/sites/default/files/fact-sheet-operation-warp-speed.pdf\\\"\u003ealso awarding contracts\u003c/a\u003e to make the millions of syringes and glass vials needed to package a COVID-19 vaccine. Without careful planning on these fronts, the U.S. could run into a demoralizing scenario where vaccines are available, but there is no way to physically get them to people.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":\"DROPCAP\",\"idAttr\":\"\",\"innerHtml\":\"E\u003cspan class=\\\"smallcaps\\\"\u003even if all\u003c/span\u003e of this goes well—the earliest candidates are effective, the trials conclude quickly, the technology works—another huge task lies ahead: When vaccines are approved, 300 million doses will not be available all at once, and a system is needed to distribute limited supplies to the public. This is exactly the sort of challenge that the U.S. government has proved unprepared for in this pandemic.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"In the H1N1 pandemic, the U.S. government purchased the vaccines and allocated doses to state and local health departments, which in turn vaccinated people through mass clinics as well as employers, schools, hospitals, pharmacies, and doctor’s offices. Nationwide, the program eventually vaccinated about \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.cidrap.umn.edu/news-perspective/2010/04/cdc-estimates-24-americans-received-h1n1-vaccine\\\"\u003ea quarter of all Americans\u003c/a\u003e—demand fell because the pandemic itself peaked not long after the vaccine became available.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"The 2009 vaccination program was built on the infrastructure of the \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.cdc.gov/H1N1flu/vaccination/statelocal/centralized_distribution_qa.htm\\\"\u003eVaccines for Children Program\u003c/a\u003e, in which the CDC buys and distributes vaccines to states for children who usually are uninsured or on Medicaid. Immunization managers who work in these programs are well versed in the intricacies of vaccine storage and distribution, such as maintaining a cold chain for vaccines that could become ineffective at room temperature. But because they work with children’s vaccines, they deal mostly with pediatrician’s offices. “We didn’t have relationships with hospitals and internists and people who vaccinated adults,” says \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.vumc.org/health-policy/person/kelly-l-moore-md-mph\\\"\u003eKelly Moore\u003c/a\u003e, who was the director of the Tennessee Immunization Program in 2009. In August that year, two months before they got their first shipment of the vaccine, Moore’s team created a sign-up on the state immunization registry and sent out a newsletter every Friday with updates and training modules for handling vaccines.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"“Unfortunately,” says Moore, “that network has not been maintained because we haven’t had other vaccines to send them in 11 years.” Contact information is out of date. Rebuilding this network for adults will be even more important with COVID-19. Although the H1N1 vaccine was recommended for all ages, the focus was on kids, for whom the flu was particularly dangerous. The opposite is true of COVID-19, which is more of a threat to older adults.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"Some of the leading COVID-19 vaccine candidates could also pose new logistical challenges, if they require storage at \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.reuters.com/article/us-health-coronavirus-vaccines-manufactu/vaccine-makers-face-biggest-medical-manufacturing-challenge-in-history-idUSKBN23W1ND\\\"\u003etemperatures as low as –80 degrees Celsius\u003c/a\u003e or multiple doses to be effective. In fact, a COVID-19 vaccine is quite likely to \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.bloomberg.com/news/articles/2020-07-20/double-shot-covid-vaccine-tests-raise-new-pandemic-challenge\\\"\u003erequire two doses\u003c/a\u003e; the first primes the immune system, allowing the second to induce a stronger immune response. Officials would have to balance giving one dose to as many people as possible with giving a second dose to those who already had one. “That was a complication we didn’t face in 2009, and we were so grateful,” says Moore.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"Although the CDC took the lead in distributing H1N1 vaccines in 2009, Claire Hannan, the executive director of the Association of Immunization Managers, says the agency has been oddly silent about plans for a COVID-19 vaccine since April. “Initially, we were having planning calls with CDC right away,” she says. “And then nothing.” She has unsuccessfully tried to get in touch with Operation Warp Speed, which \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.hhs.gov/about/news/2020/06/16/fact-sheet-explaining-operation-warp-speed.html\\\"\u003ehas suggested the Department of Defense\u003c/a\u003e may also get involved in vaccine distribution. “We continue to ask CDC these many, many questions. And they don’t know,” she says.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"The CDC’s Advisory Committee on Immunization Practices is also normally responsible for recommendations on how to prioritize vaccines. The committee, which is composed of outside experts, last met in late June, when they \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.sciencemag.org/news/2020/06/line-forming-covid-19-vaccine-who-should-be-front\\\"\u003ediscussed prioritizing vaccines\u003c/a\u003e for health-care workers, the elderly, and those with underlying conditions. They also considered prioritizing vaccination by race, given the \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.theatlantic.com/ideas/archive/2020/04/coronavirus-exposing-our-racial-divides/609526/\\\"\u003eracial disparities in COVID-19 cases\u003c/a\u003e. But now the National Academy of Medicine is convening a panel on the same topic, which is \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.statnews.com/2020/07/22/confusion-spreads-over-system-to-determine-priority-access-to-covid-19-vaccines/\\\"\u003eagain causing confusion\u003c/a\u003e about who is responsible for making these decisions.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"In 2009, Moore’s job was to put the CDC advisory committee’s recommendations into practice. Two or three times a week, she would get an email from the CDC’s vaccine distributor letting her know the number of doses available for her entire state. In practice, though, an initial shipment of vaccines might not be enough to cover everyone in even the highest priority group, such as health-care workers. It was up to people like Moore to decide which hospital got how many doses, with the promise of more on the way next week. Then individual hospitals administered the actual vaccines to their employees based on priority status.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"This system is meant to be flexible and responsive to local conditions, but it also means the availability of a vaccine might seem to vary from place to place. For example, \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.txstate.edu/anthropology/people/faculty/brunson.html\\\"\u003eEmily Brunson\u003c/a\u003e, an anthropologist at Texas State University who studies vaccines, says that in 2009 there were cases in which one district interpreted recommendations strictly, giving the vaccine only to high-priority groups, and a neighboring district offered it to anyone who wanted it. The decision to distribute the vaccine through employee health centers in New York, which happened to include several Wall Street firms, \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.cnbc.com/id/33655723\\\"\u003ealso caused a big backlash\u003c/a\u003e. “There are many ways that things can be misinterpreted,” Brunson says. And during an initial shortage, these decisions can feel unfair—especially given tensions seeded earlier in the pandemic when \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.theatlantic.com/politics/archive/2020/03/coronavirus-testing-rich-people/608062/\\\"\u003ethe rich and the famous were getting COVID-19\u003c/a\u003e tests while ordinary people were being turned away at clinics.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"If the pandemic so far is any indication, a vaccination program is likely to take place against a backdrop of partisanship and misinformation. Already, \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.bbc.com/news/52847648\\\"\u003econspiracy theories are spreading about a COVID-19 vaccine\u003c/a\u003e, some of them downright outlandish. But the emphasis on speed—as in “Operation \u003cem\u003eWarp Speed\u003c/em\u003e”—has also created real worries about vaccines being rushed to market. At a congressional hearing with five vaccine makers on Tuesday, company officials had to \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.statnews.com/2020/07/21/pharma-promises-cut-corners-covid-19-vaccine/\\\"\u003erepeatedly push back against the idea that the industry might cut corners\u003c/a\u003e for a COVID-19 vaccine.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"“We’re going to be in a situation where some people will be desperate to get the vaccine and some people will be afraid to get the vaccine. And there’ll be probably a lot of people in between who are a little bit of both or not sure,” says \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://gufaculty360.georgetown.edu/s/contact/00336000014RdeeAAC/michael-stoto\\\"\u003eMichael Stoto\u003c/a\u003e, a public-health researcher at Georgetown University. A vaccine, especially a novel one that doesn’t offer complete protection against COVID-19, will require careful communication about risk. “The fact that we can’t get ourselves straight about wearing masks will make that harder,” he adds. Given the number of Americans who are currently unsure of or opposed to getting a COVID-19 vaccine, Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, \u003ca data-event-element=\\\"inline link\\\" href=\\\"https://www.cnn.com/2020/06/28/health/fauci-coronavirus-vaccine-contact-tracing-aspen/index.html\\\"\u003ehas warned\u003c/a\u003e that even a vaccine might not get the country to herd immunity if too many people refuse it.\"},{\"__typename\":\"ArticleRelatedContentLink\",\"idAttr\":\"injected-recirculation-link-2\",\"innerHtml\":\"\u003ca href=\\\"https://www.theatlantic.com/health/archive/2020/07/herd-immunity-coronavirus/614035/\\\"\u003eRead: A new understanding of herd immunity\u003c/a\u003e\",\"index\":2},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"For the Americans pinning their hopes on a vaccine, a botched rollout could feel like yet another example of failure in the time of COVID-19. That could have disastrous consequences that last well beyond the pandemic itself. Brunson worries that such a scenario could undermine trust in public-health expertise and in all vaccines. “Both of those would be disasters,” she says, “in addition to the COVID itself being a disaster.” It could mean, for example, further resurgences of vaccine-preventable diseases such as measles and an even bigger challenge when battling future pandemics.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"For all the uncertainties that remain ahead for a COVID-19 vaccine, several experts were willing to make one prediction. “I think the question that is easy to answer is, ‘Is this virus going to go away?’ And the answer to that is, ‘\u003cem\u003eNo\u003c/em\u003e,’” says Karron, the vaccine expert at Johns Hopkins. The virus is already too widespread. A vaccine could still mitigate severe cases; it could make COVID-19 easier to live with. The virus is likely here to stay, but eventually, the pandemic will end.\"},{\"__typename\":\"ArticleParagraphContent\",\"subtype\":null,\"idAttr\":\"\",\"innerHtml\":\"\u003csmall\u003e\u003cem\u003e\u003ca data-event-element=\\\"inline link\\\" id=\\\"correction\\\" name=\\\"correction\\\"\u003e\u003c/a\u003e\u003ca data-event-element=\\\"inline link\\\" href=\\\"#corrected\\\"\u003e*\u003c/a\u003eThis piece originally identified AstraZeneca as a British-Swiss biotech company.\u003c/em\u003e\u003c/small\u003e\"}],\"editorialProject\":null,\"primaryCategory\":{\"__typename\":\"Channel\",\"displayName\":\"Health\",\"url\":\"https://www.theatlantic.com/health/\",\"slug\":\"health\"},\"reviews\":[],\"embeds\":[{\"type\":\"iframe\",\"src\":\"https://w.soundcloud.com/player/?url=https%3A//api.soundcloud.com/tracks/869401552%3Fsecret_token%3Ds-YbkigyvjltX\u0026inverse=true\u0026auto_play=false\u0026show_user=true\",\"__typename\":\"Embed\"}],\"authors\":[{\"id\":\"Author:15272\",\"displayName\":\"Sarah Zhang\",\"url\":\"https://www.theatlantic.com/author/sarah-zhang/\",\"biography\":{\"default\":\"\u003ca href=\\\"https://www.theatlantic.com/author/sarah-zhang/\\\" class=\\\"author-link\\\" data-label=\\\"https://www.theatlantic.com/author/sarah-zhang/\\\" data-action=\\\"click author - name\\\"  \u003eSarah Zhang\u003c/a\u003e is a staff writer at \u003cem\u003eThe Atlantic.\u003c/em\u003e\",\"__typename\":\"Biography\"},\"__typename\":\"Author\",\"slug\":\"sarah-zhang\",\"socialMedia\":[{\"platform\":\"TWITTER\",\"url\":\"https://twitter.com/sarahzhang\",\"__typename\":\"SocialMedia\"}]}],\"preview\":null,\"layout\":\"standard\",\"secondaryByline\":\"\",\"dek\":\"So much hope is riding on a breakthrough, but a vaccine is only the beginning of the end.\",\"url\":\"https://www.theatlantic.com/health/archive/2020/07/covid-19-vaccine-reality-check/614566/\",\"title\":\"A Vaccine Reality Check\",\"seoTitle\":\"A COVID-19 Vaccine Reality Check\",\"dateModified\":\"2021-02-23T18:53:59Z\",\"datePublished\":\"2020-07-24T14:12:42Z\",\"hasMeter\":true,\"primaryChannel\":{\"displayName\":\"Health\",\"__typename\":\"Channel\",\"slug\":\"health\"},\"shareImage1x1\":{\"width\":1080,\"height\":1080,\"url\":\"https://cdn.theatlantic.com/thumbor/tCfwm2aoxKmojZQFFZwA3bFplTY=/288x0:1488x1200/1080x1080/media/img/mt/2020/07/vaccine/original.jpg\",\"__typename\":\"BasicImage\"},\"shareImage16x9\":{\"width\":1600,\"height\":900,\"url\":\"https://cdn.theatlantic.com/thumbor/t17vZplO_1uKBgUzhDtfOsRH6x0=/0x0:2000x1125/1600x900/media/img/mt/2020/07/vaccine/original.jpg\",\"__typename\":\"BasicImage\"},\"shareImage4x3\":{\"width\":1200,\"height\":900,\"url\":\"https://cdn.theatlantic.com/thumbor/bIBd-MKkwS4qolxCoiMqpuyw3-E=/201x0:1801x1200/1200x900/media/img/mt/2020/07/vaccine/original.jpg\",\"__typename\":\"BasicImage\"},\"shareImageDefault\":{\"width\":960,\"height\":540,\"url\":\"https://cdn.theatlantic.com/thumbor/qK60q2VIyUzp6LkmcZ4UQd-UFLA=/0x0:2000x1125/960x540/media/img/mt/2020/07/vaccine/original.jpg\",\"__typename\":\"BasicImage\"},\"shareImageSquareDefault\":{\"width\":540,\"height\":540,\"url\":\"https://cdn.theatlantic.com/thumbor/m4MP7qujn6bnjuE9ZcCH_fgHXus=/288x0:1488x1200/540x540/media/img/mt/2020/07/vaccine/original.jpg\",\"__typename\":\"BasicImage\"},\"shareImageLeadArt\":{\"image\":{\"width\":720,\"height\":405,\"url\":\"https://cdn.theatlantic.com/thumbor/ZcTdBc0e0-M1_DLPH-aapb21b88=/0x0:2000x1125/720x405/media/img/mt/2020/07/vaccine/original.jpg\",\"__typename\":\"BasicImage\"},\"__typename\":\"LeadArtImage\"},\"shareDek\":\"So much hope is riding on a breakthrough, but a vaccine is only the beginning of the end.\",\"shareText\":\"Even on a sped-up timeline a vaccine is still months away. But once it arrives it's unlikely to meet all the hopes we've placed in it, writes @sarahzhang:\",\"shareTitle\":\"A Vaccine Reality Check\",\"editorsNote\":null,\"leadArt\":{\"__typename\":\"LeadArtImage\",\"image\":{\"url\":\"https://cdn.theatlantic.com/thumbor/qK60q2VIyUzp6LkmcZ4UQd-UFLA=/0x0:2000x1125/960x540/media/img/mt/2020/07/vaccine/original.jpg\",\"width\":960,\"height\":540,\"srcSet\":\"https://cdn.theatlantic.com/thumbor/cKLkauea62Nlf75LVVYCK4H9r5s=/0x0:2000x1125/750x422/media/img/mt/2020/07/vaccine/original.jpg 750w, https://cdn.theatlantic.com/thumbor/c4qgE2R4322aq0_K0NTdKQSrHLk=/0x0:2000x1125/828x466/media/img/mt/2020/07/vaccine/original.jpg 828w, https://cdn.theatlantic.com/thumbor/qK60q2VIyUzp6LkmcZ4UQd-UFLA=/0x0:2000x1125/960x540/media/img/mt/2020/07/vaccine/original.jpg 960w, https://cdn.theatlantic.com/thumbor/UdTFdSQJm09i7wMw092LNkJ7bfQ=/0x0:2000x1125/976x549/media/img/mt/2020/07/vaccine/original.jpg 976w, https://cdn.theatlantic.com/thumbor/u7u8OF_Iu9rFRkYl02ps9CxArhs=/0x0:2000x1125/1952x1098/media/img/mt/2020/07/vaccine/original.jpg 1952w\",\"reducedMotionSrcSet\":null,\"altText\":\"Illustration of praying hands, surrounded by syringes\",\"captionText\":\"\",\"attributionText\":\"The Atlantic\",\"attributionUrl\":\"\",\"__typename\":\"BasicImage\"}},\"narratedAudio\":null,\"hasAudioRights\":null,\"narratedAudioImage\":{\"url\":\"https://cdn.theatlantic.com/thumbor/gYvvi0WBjtzw3CeeK2Al1y04u-g=/288x0:1488x1200/80x80/media/img/mt/2020/07/vaccine/original.jpg\",\"srcSet\":\"https://cdn.theatlantic.com/thumbor/gYvvi0WBjtzw3CeeK2Al1y04u-g=/288x0:1488x1200/80x80/media/img/mt/2020/07/vaccine/original.jpg 80w, https://cdn.theatlantic.com/thumbor/Ac7dWBX_CV1m8gJYaLo8pmbazGo=/288x0:1488x1200/96x96/media/img/mt/2020/07/vaccine/original.jpg 96w, https://cdn.theatlantic.com/thumbor/6r3KAB8kDFcXJtmGb7KpZLk6E5Q=/288x0:1488x1200/128x128/media/img/mt/2020/07/vaccine/original.jpg 128w, https://cdn.theatlantic.com/thumbor/_Cq0ZvWXqnGUTP6DKJ72DGY7CTI=/288x0:1488x1200/160x160/media/img/mt/2020/07/vaccine/original.jpg 160w, https://cdn.theatlantic.com/thumbor/TahxFlnbbml2fvpFDRUvgXyuDuY=/288x0:1488x1200/192x192/media/img/mt/2020/07/vaccine/original.jpg 192w, https://cdn.theatlantic.com/thumbor/F85NI_QWFg1pwMe433tIXU_6Rjk=/288x0:1488x1200/256x256/media/img/mt/2020/07/vaccine/original.jpg 256w, https://cdn.theatlantic.com/thumbor/ZSqIWOLpfPcoOa59M8YaGxuOgF4=/288x0:1488x1200/384x384/media/img/mt/2020/07/vaccine/original.jpg 384w, https://cdn.theatlantic.com/thumbor/55zVPlQ52Faa2sBlaBY148FrC1U=/288x0:1488x1200/512x512/media/img/mt/2020/07/vaccine/original.jpg 512w\",\"width\":80,\"height\":80,\"altText\":\"Illustration of praying hands, surrounded by syringes\",\"__typename\":\"BasicImage\"},\"fbiaUrl\":\"https://www.theatlantic.com/facebook-instant/article/614566/\",\"canonicalUrl\":\"https://www.theatlantic.com/health/archive/2020/07/covid-19-vaccine-reality-check/614566/\",\"syndication\":\"ALL\",\"shareImage2x1\":{\"url\":\"https://cdn.theatlantic.com/thumbor/NW2cvzKrcby91SzmIiqES4YNWvM=/0x43:2000x1085/1200x625/media/img/mt/2020/07/vaccine/original.jpg\",\"height\":625,\"width\":1200,\"__typename\":\"BasicImage\"},\"shareImageGift2x1\":{\"url\":\"https://cdn.theatlantic.com/thumbor/ltRJ9XgMy5iXhsUUcXoJmGAr-ao=/0x43:2000x1085/1200x625/filters:watermark(https://cdn.theatlantic.com/media/files/badge_2x.png,-20,20,0,33)/media/img/mt/2020/07/vaccine/original.jpg\",\"height\":625,\"width\":1200,\"__typename\":\"BasicImage\"},\"shareImageGiftSmall\":{\"url\":\"https://cdn.theatlantic.com/thumbor/I3NcSi73F7N-cZj2qQDFfswRH6Q=/4x41:1996x1087/960x504/filters:watermark(https://cdn.theatlantic.com/media/files/badge_2x.png,-20,20,0,33)/media/img/mt/2020/07/vaccine/original.jpg\",\"height\":504,\"width\":960,\"__typename\":\"BasicImage\"},\"shareImageSmall\":{\"url\":\"https://cdn.theatlantic.com/thumbor/OC855HBLPFhQ7P0yimZWE3YjTVs=/4x41:1996x1087/960x504/media/img/mt/2020/07/vaccine/original.jpg\",\"height\":504,\"width\":960,\"__typename\":\"BasicImage\"},\"channels\":[{\"slug\":\"health\",\"__typename\":\"Channel\"},{\"slug\":\"science\",\"__typename\":\"Channel\"}],\"watsonInfo\":{\"keywords\":[\"hypothetical vaccine\",\"COVID-19 virus\",\"COVID-19 vaccine\",\"rosy projections of a vaccine\",\"blow coverage of vaccine trials\",\"much simpler task\",\"H1N1\",\"record time\",\"vaccine optimism\",\"director of the National Immunization Program\",\"vaccine\",\"given participant\",\"director of the World Health Organization\",\"initial results\",\"local health departments\",\"good news\",\"immune system\",\"FDA’s pandemic response\",\"Trump administration’s Operation Warp Speed\",\"American company\",\"CDC buys\",\"vaccine distribution efforts\",\"director of the University of Maryland\",\"willingness of people\",\"Trump administration\",\"candidate vaccines\",\"human trials\",\"long-term immune response\",\"early success\",\"Kelly Moore\",\"careful planning\",\"Disease Control\",\"good reasons\",\"Normal life\",\"recent weeks\",\"promise of a vaccine\",\"herd immunity\",\"high expectations\",\"federal government\",\"patchwork of state\",\"next challenges\",\"Emory University\",\"real world\",\"late June\",\"COVID-19 vaccines\",\"huge group\",\"severe disease\",\"given amount of eggs\",\"older adults.Some of the leading COVID-19\",\"Johns Hopkins University\"],\"__typename\":\"WatsonInfo\"},\"slug\":\"covid-19-vaccine-reality-check\",\"grapeshot\":{\"segments\":[\"gv_safe\",\"gb_safe\",\"pos_gucci\",\"pos_israel_conflict\",\"pos_mastercard\",\"pos_oceangate\",\"pos_safe_core\",\"pos_safe_strict\",\"pos_safety_delta\",\"gs_health\",\"gs_health_misc\",\"gs_covid19\",\"shadow9hu7_pos_goldman_sachs\",\"gs_health_vaccines\",\"gs_busfin\",\"shadow9hu7_pos_bofa-kwlist\",\"gt_negative\"],\"__typename\":\"Grapeshot\"},\"tags\":[]}}"},"2021745665":{"data":"{\"breakingNews\":null}"},"2282500307":{"data":"{\"article\":{\"primaryCategory\":{\"__typename\":\"Channel\"},\"editorialProject\":null,\"__typename\":\"BlogArticle\"}}"},"2295516796":{"data":"{\"article\":{\"id\":\"BlogArticle:614566\",\"isTnfCompatible\":true,\"layout\":\"standard\",\"hasMeter\":true,\"url\":\"https://www.theatlantic.com/health/archive/2020/07/covid-19-vaccine-reality-check/614566/\",\"dateModified\":\"2021-02-23T18:53:59Z\",\"__typename\":\"BlogArticle\"}}"}},"urqlClient":null},"isSocialBot":false},"page":"/[channel]/archive/[year]/[month]/[slug]/[id]","query":{"channel":"health","year":"2020","month":"07","slug":"covid-19-vaccine-reality-check","id":"614566"},"buildId":"e12f2951f2","assetPrefix":"https://cdn.theatlantic.com","runtimeConfig":{"GTM_CONTAINER_ID":"GTM-NTQTB9V","GTM_CONTAINER_ID_NONCONSENTED":"GTM-5839GV7","GRAPHQL_API_URL":"https://graphql.theatlantic.com","GRAPHQL_API_KEY":"JakhyMEXwa9odtB8gBxFI63ITyKqDGkn7ciGVIJf","ADS_LIB_URL":"https://www.theatlantic.com/packages/hummingbirdjs/hummingbird.min.js","ACCOUNTS_FRONTEND_URL":"https://accounts.theatlantic.com","ENABLE_FEATURE_ARTICLE_RENDER":"false","RECAPTCHA_SITE_KEY":"6Lc9Z7AUAAAAAEYS1dgAG2_6tT3KLqZQ1z4kbDRc"},"isFallback":false,"dynamicIds":[46449,52839],"gip":true,"appGip":true,"scriptLoader":[]}</script><script nomodule="" src="https://cdn.theatlantic.com/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script async="" src="https://cdn.theatlantic.com/_next/static/chunks/6449.a042cba4e409376f.js"></script><script async="" src="https://cdn.theatlantic.com/_next/static/chunks/2839.8701ee48b3142129.js"></script><script src="https://cdn.theatlantic.com/_next/static/chunks/webpack-8be99a45ef49291a.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/framework-2114f3935436c3d0.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/main-61b21f44401e8a5c.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/pages/_app-334f9b7f2dda768e.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/6729-85e40cec85603df8.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/5303-aa03f19b365778fd.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/2746-f19d6369806ca564.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/1902-6d7b58897f1bfa3b.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/2739-516bd5912f0bb1d8.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/3634-78db02a401df82c2.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/8879-1834efe4206c6b1c.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/4634-74c19fdccf77b65c.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/6759-404ffcc76f0619cc.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/7218-70290618c2e802bb.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/7455-e721c97706669282.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/7124-4bf2b2d7b62898f6.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/4603-1caa64ad3f882c0c.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/chunks/pages/%5Bchannel%5D/archive/%5Byear%5D/%5Bmonth%5D/%5Bslug%5D/%5Bid%5D-1989daf459a7e5aa.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/e12f2951f2/_buildManifest.js" async=""></script><script src="https://cdn.theatlantic.com/_next/static/e12f2951f2/_ssgManifest.js" async=""></script></body></html> contentType 9 text/html url 93 https://www.theatlantic.com:443/health/archive/2020/07/covid-19-vaccine-reality-check/614566/ responseCode 3 200 